<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27090305</article-id>
<article-id pub-id-type="pmc">4879184</article-id>
<article-id pub-id-type="pii">mp201650</article-id>
<article-id pub-id-type="doi">10.1038/mp.2016.50</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Expert Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways</article-title>
<alt-title alt-title-type="running">Gut dysbiosis, altered brain function, and mental illness</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rogers</surname>
<given-names>G B</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keating</surname>
<given-names>D J</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Young</surname>
<given-names>R L</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wong</surname>
<given-names>M-L</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Licinio</surname>
<given-names>J</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wesselingh</surname>
<given-names>S</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>South Australian Health and Medical Research Institute, Infection and Immunity Theme, School of Medicine, Flinders University</institution>, Adelaide, SA, <country>Australia</country></aff>
<aff id="aff2"><label>2</label><institution>South Australian Health and Medical Research Institute, Centre for Neuroscience and Department of Human Physiology, Flinders University</institution>, Adelaide, SA, <country>Australia</country></aff>
<aff id="aff3"><label>3</label><institution>South Australian Health and Medical Research Institute, Department of Medicine, University of Adelaide</institution>, Adelaide, SA, <country>Australia</country></aff>
<aff id="aff4"><label>4</label><institution>South Australian Health and Medical Research Institute, Mind and Brain Theme, and Flinders University</institution>, Adelaide, SA, <country>Australia</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Microbiology and Infectious Diseases, 5D332, Flinders Medical Centre</institution>, Flinders Drive, Bedford Park, Adelaide 5042, SA, <country>Australia</country>. E-mail: <email>geraint.rogers@sahmri.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>06</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>04</month>
<year>2016</year>
</pub-date>
<volume>21</volume>
<issue>6</issue>
<fpage>738</fpage>
<lpage>748</lpage>
<history>
<date date-type="received">
<day>15</day>
<month>02</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>02</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>02</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Macmillan Publishers Limited</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Macmillan Publishers Limited</copyright-holder>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--author-paid-->
<license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></license-p>
</license>
</permissions>
<abstract>
<p>The human body hosts an enormous abundance and diversity of microbes, which perform a range of essential and beneficial functions. Our appreciation of the importance of these microbial communities to many aspects of human physiology has grown dramatically in recent years. We know, for example, that animals raised in a germ-free environment exhibit substantially altered immune and metabolic function, while the disruption of commensal microbiota in humans is associated with the development of a growing number of diseases. Evidence is now emerging that, through interactions with the gut–brain axis, the bidirectional communication system between the central nervous system and the gastrointestinal tract, the gut microbiome can also influence neural development, cognition and behaviour, with recent evidence that changes in behaviour alter gut microbiota composition, while modifications of the microbiome can induce depressive-like behaviours. Although an association between enteropathy and certain psychiatric conditions has long been recognized, it now appears that gut microbes represent direct mediators of psychopathology. Here, we examine roles of gut microbiome in shaping brain development and neurological function, and the mechanisms by which it can contribute to mental illness. Further, we discuss how the insight provided by this new and exciting field of research can inform care and provide a basis for the design of novel, microbiota-targeted, therapies.</p>
</abstract>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>The disruption of the microbes that are resident in our gastrointestinal tract has long been implicated in the development or exacerbation of mental disorders. There is, for example, a long history of anecdotal reports of psychiatric side-effects of antibiotics, even in those without a premorbid psychiatric history.<sup><xref ref-type="bibr" rid="bib1">1</xref></sup> There have also been attempts to influence the composition of the gut microbiota to achieve clinical benefit. For example, in the first decades of the twentieth century, probiotic preparations containing <italic>Lactobacillus</italic> strains were marketed widely as a means to improve mental health or treat psychiatric disorders.<sup><xref ref-type="bibr" rid="bib2">2</xref></sup> These approaches fell from favour in the 1920s because of a lack of mechanistic understanding and their link to the increasingly unfashionable ‘autointoxication' model. However, the interest in the role of gut microbes in mental health, and our ability to improve psychiatric wellbeing through their manipulation, is resurgent.<sup><xref ref-type="bibr" rid="bib2">2</xref>, <xref ref-type="bibr" rid="bib3">3</xref></sup></p>
<p>In this review, we consider the potential of dysbiosis to contribute to psychopathology and the evidence linking disruption of gut microbiota with specific psychiatric disorders. We examine the role of the microbiome in neurological development and regulation, and consider its contribution to aging-related morbidity. Finally, we discuss the potential for modification of the gut microbiome to provide clinical benefit in the context of altered brain function.</p>
</sec>
<sec>
<title>Regulation of neurological function by the gut microbiome</title>
<p>The potential contribution of bidirectional communication between the gut and central nervous system (CNS) is suggested by high rates of comorbidity between gastrointestinal and psychiatric illnesses.<sup><xref ref-type="bibr" rid="bib4">4</xref>, <xref ref-type="bibr" rid="bib5">5</xref></sup> For example, mood disorders affect more than half of all patients with irritable bowel syndrome,<sup><xref ref-type="bibr" rid="bib6">6</xref></sup> with antidepressants being one of the most common pharmaceutical interventions for irritable bowel syndrome.<sup><xref ref-type="bibr" rid="bib4">4</xref></sup> The gut–brain axis consists of a bidirectional communication network that monitors and integrates gut functions and link them to cognitive and emotional centres of the brain. It encompasses the central, autonomic and enteric nervous systems, as well as the neuroendocrine, enteroendocrine and neuroimmune systems.<sup><xref ref-type="bibr" rid="bib7">7</xref>, <xref ref-type="bibr" rid="bib8">8</xref></sup> It mediates the effects of both genetic and environmental factors on brain development and function, and has been implicated in the aetiology of a number of psychiatric disorders.<sup><xref ref-type="bibr" rid="bib9">9</xref>, <xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref></sup></p>
<p>In recent years, we have increasingly understood the contribution made by the gut microbiome not only in the regulation of host physiology, particularly metabolism and immunity,<sup><xref ref-type="bibr" rid="bib13">13</xref>, <xref ref-type="bibr" rid="bib14">14</xref>, <xref ref-type="bibr" rid="bib15">15</xref>, <xref ref-type="bibr" rid="bib16">16</xref>, <xref ref-type="bibr" rid="bib17">17</xref></sup> but also the CNS and brain function.<sup><xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib18">18</xref>, <xref ref-type="bibr" rid="bib19">19</xref></sup> Given mounting evidence that the microbiome has a key role in influencing the development and function of the nervous system through its interaction with the gut–brain axis, it has been suggested that a ‘microbiome–gut–brain axis' may be a more appropriate model.<sup><xref ref-type="bibr" rid="bib19">19</xref>, <xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib21">21</xref>, <xref ref-type="bibr" rid="bib22">22</xref></sup></p>
<p>The delicate balance between the human microbiome and the development of psychopathologies is particularly interesting given the ease with which the microbiome can be altered by external factors, such as diet,<sup><xref ref-type="bibr" rid="bib23">23</xref></sup> exposure to antimicrobials<sup><xref ref-type="bibr" rid="bib24">24</xref>, <xref ref-type="bibr" rid="bib25">25</xref></sup> or disrupted sleep patterns.<sup><xref ref-type="bibr" rid="bib26">26</xref></sup> For example, a link between antibiotic exposure and altered brain function is well evidenced by the psychiatric side-effects of antibiotics, which range from anxiety and panic to major depression, psychosis and delirium.<sup><xref ref-type="bibr" rid="bib1">1</xref></sup> A recent large population study reported that treatment with a single antibiotic course was associated with an increased risk for depression and anxiety, rising with multiple exposures.<sup><xref ref-type="bibr" rid="bib27">27</xref></sup> Bercik <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib28">28</xref></sup> showed that oral administration of non-absorbable antimicrobials transiently altered the composition of the gut microbiota in adult mice and increased exploratory behaviour and hippocampal expression of brain-derived neurotrophic factor (BDNF), while intraperitoneal administration had no effect on behaviour. Alteration of brain function may therefore add to the many reasons that inappropriate antibiotic use should be avoided. It should be noted though that unchecked bacterial infection also represents an acute stressor, and has been shown to be associated with memory dysfunction in mice.<sup><xref ref-type="bibr" rid="bib29">29</xref></sup></p>
<p>Diet is another important determinant of gut microbiota composition and function that is strongly linked with psychopathological outcomes. For example, consumption of high fat diet (HFD) is associated with altered microbial diversity and reduced synaptic plasticity,<sup><xref ref-type="bibr" rid="bib30">30</xref>, <xref ref-type="bibr" rid="bib31">31</xref></sup> with increased vulnerability to anxiety-like behaviour in mice,<sup><xref ref-type="bibr" rid="bib32">32</xref></sup> while altered microbial diversity upon consumption of a diet high in sucrose results in significantly impaired development of a spatial bias for long-term memory, short-term memory and reversal training.<sup><xref ref-type="bibr" rid="bib33">33</xref></sup> In contrast, adolescent rats fed a low-calorie diet show augmented neurogenesis and BDNF levels, and improved cognition in adulthood,<sup><xref ref-type="bibr" rid="bib34">34</xref></sup> and a diet that increases microbiota diversity is associated with improved cognitive ability.<sup><xref ref-type="bibr" rid="bib35">35</xref></sup> Although human data have shown reduced microbial diversity in individuals is linked with increased adiposity, insulin resistance, dyslipidaemia and more pronounced inflammatory phenotype,<sup><xref ref-type="bibr" rid="bib36">36</xref>, <xref ref-type="bibr" rid="bib37">37</xref></sup> strong evidence of a direct microbiome effect comes from studies using conventionally housed mice subjected to a microbiome depletion and/or transplantation paradigm using microbiota isolated from donors on either an HFD or control diet. Following re-colonization, mice given the HFD exposed microbiota showed significant and selective disruptions in exploratory, cognitive, and stereotypical behaviour.<sup><xref ref-type="bibr" rid="bib38">38</xref></sup> Although it is not possible to exclude the direct effect of host metabolism on brain function, such findings do suggest that diet-induced changes in the intestinal microbiome substantially influence brain function.</p>
<p>Diet and antibiotic exposure are only two factors that potentially influence brain function through shaping the gut microbiome (<xref ref-type="fig" rid="fig1">Figure 1</xref>). An array of common variables may be equally important. For example, alcohol consumption,<sup><xref ref-type="bibr" rid="bib39">39</xref>, <xref ref-type="bibr" rid="bib40">40</xref></sup> smoking habits<sup><xref ref-type="bibr" rid="bib41">41</xref></sup> and disruption of diurnal rhythm,<sup><xref ref-type="bibr" rid="bib26">26</xref></sup> have all been shown to substantially affect microbiota composition. As such, how wider influences on the microbiome contribute to dysregulation of brain function is an area of growing interest.</p>
</sec>
<sec>
<title>The microbiome in specific psychiatric conditions</title>
<p>While the links between the microbiome and specific psychiatric conditions have been reviewed elsewhere,<sup><xref ref-type="bibr" rid="bib18">18</xref>, <xref ref-type="bibr" rid="bib42">42</xref>, <xref ref-type="bibr" rid="bib43">43</xref>, <xref ref-type="bibr" rid="bib44">44</xref>, <xref ref-type="bibr" rid="bib45">45</xref></sup> a brief examination of the contribution of inter-kingdom interactions to two particularly distressing neuropsychiatric disorders provides a useful illustration.</p>
<p>Major depressive disorder (MDD) is typified by markers known to be influenced by the microbiome. For example, depression-associated changes seen in the hypothalamic-pituitary-adrenal (HPA) stress response,<sup><xref ref-type="bibr" rid="bib46">46</xref></sup> and altered levels of depression-associated monoamines (or their receptors) in corticolimbic regions of the brain, have both been demonstrated in germ-free (GF) mice.<sup><xref ref-type="bibr" rid="bib28">28</xref>, <xref ref-type="bibr" rid="bib47">47</xref>, <xref ref-type="bibr" rid="bib48">48</xref>, <xref ref-type="bibr" rid="bib49">49</xref>, <xref ref-type="bibr" rid="bib50">50</xref></sup> The increased concentrations of pro-inflammatory cytokines seen in MDD<sup><xref ref-type="bibr" rid="bib46">46</xref></sup> may also result from interactions with gut microbes. Levels of serum antibodies against lipopolysaccharide from gram-negative enterobacteria are higher in patients with MDD than in controls,<sup><xref ref-type="bibr" rid="bib51">51</xref></sup> and cause stress-associated with increased gut permeability and bacterial translocation in animal models.<sup><xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib52">52</xref></sup> Evidence also exists that depression alters the gut microbiota, as demonstrated in mice in which chronic depression- and anxiety-like behaviours has been induced by olfactory bulbectomy,<sup><xref ref-type="bibr" rid="bib53">53</xref></sup> suggesting a feedback loop between depressive states and dysbiosis. A reflection of the importance of this circular relationship may be the existence of host mechanisms that regulate microbiota composition.<sup><xref ref-type="bibr" rid="bib54">54</xref>, <xref ref-type="bibr" rid="bib55">55</xref></sup></p>
<p>Similar parallels between dysbiosis and psychopathogenesis exist in schizophrenia (reviewed by Dinan <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib56">56</xref></sup> and Nemani <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib44">44</xref></sup>). Many of the strongest associations identified between genetic risk and schizophrenia relate to genes involved in immunity,<sup><xref ref-type="bibr" rid="bib57">57</xref>, <xref ref-type="bibr" rid="bib58">58</xref></sup> paralleling clinical studies that report an upregulated immune and inflammatory status in schizophrenia patients.<sup><xref ref-type="bibr" rid="bib59">59</xref>, <xref ref-type="bibr" rid="bib60">60</xref>, <xref ref-type="bibr" rid="bib61">61</xref>, <xref ref-type="bibr" rid="bib62">62</xref>, <xref ref-type="bibr" rid="bib63">63</xref>, <xref ref-type="bibr" rid="bib64">64</xref>, <xref ref-type="bibr" rid="bib65">65</xref>, <xref ref-type="bibr" rid="bib66">66</xref>, <xref ref-type="bibr" rid="bib67">67</xref>, <xref ref-type="bibr" rid="bib68">68</xref></sup> Serological markers of bacterial translocation are also substantially elevated in schizophrenia subjects and significantly correlated with systemic inflammatory markers.<sup><xref ref-type="bibr" rid="bib69">69</xref></sup> In turn, cytokine levels are correlated with the severity of clinical symptoms,<sup><xref ref-type="bibr" rid="bib59">59</xref>, <xref ref-type="bibr" rid="bib70">70</xref>, <xref ref-type="bibr" rid="bib71">71</xref></sup> and it has been suggested that the resulting neuroinflammation is involved directly in schizophrenia pathogenesis.<sup><xref ref-type="bibr" rid="bib72">72</xref>, <xref ref-type="bibr" rid="bib73">73</xref>, <xref ref-type="bibr" rid="bib74">74</xref></sup></p>
<p>As described later, the microbiota also modulate a range of neurotrophins and proteins involved in brain development and plasticity.<sup><xref ref-type="bibr" rid="bib48">48</xref>, <xref ref-type="bibr" rid="bib49">49</xref>, <xref ref-type="bibr" rid="bib75">75</xref></sup> There is evidence that such alterations are central to the pathophysiology of schizophrenia. For example, BDNF expression is believed to have a role in the molecular mechanism underlying altered cognition,<sup><xref ref-type="bibr" rid="bib76">76</xref></sup> and through its influence on brain plasticity, may contribute to the <italic>N</italic>-methyl-<sc>d</sc>-aspartate receptor dysfunction seen in schizophrenia.<sup><xref ref-type="bibr" rid="bib77">77</xref></sup></p>
</sec>
<sec>
<title>Treatment interactions with the microbiome in mental illness</title>
<p>In addition to influencing psychopathogenesis directly, the gut microbiome makes an important contribution to drug metabolism, and potentially explains much of the inter-individual variability in treatment efficacy and side-effects.<sup><xref ref-type="bibr" rid="bib78">78</xref>, <xref ref-type="bibr" rid="bib79">79</xref></sup> For example, the gut microbiota has been implicated in the reductive metabolism of psychotropic medications, including benzodiazepine clonazepam,<sup><xref ref-type="bibr" rid="bib80">80</xref></sup> risperidone<sup><xref ref-type="bibr" rid="bib81">81</xref></sup> and levodopa.<sup><xref ref-type="bibr" rid="bib82">82</xref></sup> In addition, the gut microbiome is also able to influence the gene expression of hepatic enzymes that aid in the metabolism and detoxification of drugs outside of the gut.<sup><xref ref-type="bibr" rid="bib83">83</xref>, <xref ref-type="bibr" rid="bib84">84</xref></sup></p>
<p>A reciprocal interaction also exists, with drugs used to target psychiatric or neurological disorders having the potential to affect the composition and function of the gut microbiome. For example, the atypical antipsychotic olazapine has been shown to affect microbiota composition in rats, as well as triggering inflammatory effects and weight gain,<sup><xref ref-type="bibr" rid="bib85">85</xref>, <xref ref-type="bibr" rid="bib86">86</xref></sup> with the co-administration of antibiotics shown to attenuate these physiological effects.<sup><xref ref-type="bibr" rid="bib87">87</xref></sup> The impact of atypical antipsychotics on the gut microbiota may therefore explain to some extent the increased levels of cardiac and metabolic disease in patients receiving these medications.<sup><xref ref-type="bibr" rid="bib88">88</xref>, <xref ref-type="bibr" rid="bib89">89</xref>, <xref ref-type="bibr" rid="bib90">90</xref></sup></p>
<p>The clinical implications of these pathways remain poorly understood, but suggest the utility of a precision approach to therapy, as has been advocated in psychiatry<sup><xref ref-type="bibr" rid="bib91">91</xref>, <xref ref-type="bibr" rid="bib92">92</xref></sup> and other disease contexts.<sup><xref ref-type="bibr" rid="bib93">93</xref></sup></p>
</sec>
<sec>
<title>The role of the microbiome in brain development</title>
<sec>
<title>Prenatal neurodevelopment</title>
<p>Brain development spans the prenatal period to post adolescence and involves the interplay of genetic and environmental factors.<sup><xref ref-type="bibr" rid="bib94">94</xref></sup> Disruption of these interactions can alter normal developmental trajectories and contribute substantially to neuropsychiatric outcomes in later in life.<sup><xref ref-type="bibr" rid="bib95">95</xref>, <xref ref-type="bibr" rid="bib96">96</xref></sup></p>
<p>Neural development begins early in embryonic life with a number of important stages occurring before birth.<sup><xref ref-type="bibr" rid="bib94">94</xref></sup> Areas of the brain undergoing these events exhibit greater fragility<sup><xref ref-type="bibr" rid="bib97">97</xref></sup> and the significant impact of insults that occur during gestation is increasingly recognized.<sup><xref ref-type="bibr" rid="bib98">98</xref></sup> During this period, maternal immunity and metabolism represents a link between neurodevelopment in the womb and the external environment. Challenges to maternal homoeostasis, such as infection, poor nutrition or prenatal stress (PNS), are associated with neurodevelopmental disorders, including anxiety, autism, attention deficit hyperactivity disorder, depression and schizophrenia.<sup><xref ref-type="bibr" rid="bib99">99</xref>, <xref ref-type="bibr" rid="bib100">100</xref>, <xref ref-type="bibr" rid="bib101">101</xref>, <xref ref-type="bibr" rid="bib102">102</xref>, <xref ref-type="bibr" rid="bib103">103</xref>, <xref ref-type="bibr" rid="bib104">104</xref>, <xref ref-type="bibr" rid="bib105">105</xref>, <xref ref-type="bibr" rid="bib106">106</xref>, <xref ref-type="bibr" rid="bib107">107</xref>, <xref ref-type="bibr" rid="bib108">108</xref>, <xref ref-type="bibr" rid="bib109">109</xref></sup> Disruption of the maternal microbiome, or ‘dysbiosis', appears to act as a link between external stressors and fetal development, either by altering normal developmental cues, or through the presentation of inappropriate developmental stimuli.</p>
<p>The precise nature of relationships between maternal microbiome interactions, altered neurodevelopment and subsequent psychopathologies, remain poorly defined. To a large extent, this is due to the challenge of determining the relative contribution of parallel and overlapping pathways that link multiple interacting systems. Even in animal models, it is extremely difficult to identify the relative contribution of pathways by which a single factor can lead to an array of behavioural disorders. As an illustration, the consumption of a HFD during pregnancy is associated with subsequent behavioural disorders.<sup><xref ref-type="bibr" rid="bib110">110</xref>, <xref ref-type="bibr" rid="bib111">111</xref></sup> However, HFD has been shown to influence multiple regulatory pathways in the immune,<sup><xref ref-type="bibr" rid="bib112">112</xref>, <xref ref-type="bibr" rid="bib113">113</xref></sup> metabolic<sup><xref ref-type="bibr" rid="bib114">114</xref></sup> and neuroendocrine<sup><xref ref-type="bibr" rid="bib110">110</xref></sup> systems, through both microbiome dependent and independent mechanisms, as well as resulting in the vertical transmission of the associated dysbiosis.<sup><xref ref-type="bibr" rid="bib25">25</xref></sup> Further, the impact of an insult such as HFD consumption depends on the developmental stage at which it occurs, with similar adverse events during early or late periods associated with different outcomes.<sup><xref ref-type="bibr" rid="bib105">105</xref>, <xref ref-type="bibr" rid="bib115">115</xref>, <xref ref-type="bibr" rid="bib116">116</xref></sup></p>
<p>One important contributor to aberrant neurodevelopment appears to be the disruption of the immuno-regulatory role of the gut microbiome, resulting in a pro-inflammatory maternal state. Increased levels of circulating cytokines during pregnancy have been shown to negatively affect neural development <sup><xref ref-type="bibr" rid="bib110">110</xref></sup> and could act by altering the fetal immune milieu (reviewed in detail elsewhere<sup><xref ref-type="bibr" rid="bib94">94</xref>, <xref ref-type="bibr" rid="bib117">117</xref>, <xref ref-type="bibr" rid="bib118">118</xref>, <xref ref-type="bibr" rid="bib119">119</xref></sup>).</p>
<p>Immune-dysregulation could result from factors that ablate the normal microbiota, such as antibiotics, thereby suppressing microbial interactions with toll-like receptors and Treg cells in the gut<sup><xref ref-type="bibr" rid="bib120">120</xref>, <xref ref-type="bibr" rid="bib121">121</xref>, <xref ref-type="bibr" rid="bib122">122</xref></sup> or the production of immuno-regulatory metabolites, such as short-chain fatty acids (SCFAs).<sup><xref ref-type="bibr" rid="bib122">122</xref>, <xref ref-type="bibr" rid="bib123">123</xref>, <xref ref-type="bibr" rid="bib124">124</xref></sup> Alternatively, factors that trigger dysbiosis, such as high fat consumption, could act by promoting the production of pro-inflammatory bacterial metabolites.<sup><xref ref-type="bibr" rid="bib125">125</xref></sup> In addition, the dysbiotic changes in the gut microbiota could influence inflammation and CNS function through changes in activation of vagal and/or spinal nerve pathways.<sup><xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib108">108</xref>, <xref ref-type="bibr" rid="bib126">126</xref>, <xref ref-type="bibr" rid="bib127">127</xref></sup> The contribution of such a microbiota-immune interaction to stress-associated pathologies is supported by the observation that exposure to repeated stress affects the gut microbiota in a manner that correlates with changes in levels of pro-inflammatory cytokines.<sup><xref ref-type="bibr" rid="bib128">128</xref></sup></p>
<p>The maternal HPA axis is likely to represent another important link between prenatal insults and developmental abnormalities. The HPA axis is affected by factors such as PNS<sup><xref ref-type="bibr" rid="bib129">129</xref>, <xref ref-type="bibr" rid="bib130">130</xref></sup> and infection,<sup><xref ref-type="bibr" rid="bib131">131</xref></sup> which are risk factors for a wide range of neurodevelopmental disorders.<sup><xref ref-type="bibr" rid="bib132">132</xref>, <xref ref-type="bibr" rid="bib133">133</xref>, <xref ref-type="bibr" rid="bib134">134</xref>, <xref ref-type="bibr" rid="bib135">135</xref>, <xref ref-type="bibr" rid="bib136">136</xref></sup> In animal models of early-life postnatal stress, hyper-responsiveness of the HPA axis is coupled with altered visceral pain sensitivity and impaired intestinal barrier function,<sup><xref ref-type="bibr" rid="bib137">137</xref>, <xref ref-type="bibr" rid="bib138">138</xref></sup> while aberrant dietary protein:carbohydrate ratios during gestation have moderate long-term effects on the function of the HPA and sympatho-adrenomedullary axes in offspring.<sup><xref ref-type="bibr" rid="bib139">139</xref></sup> It is useful to note direct responses to <italic>in utero</italic> stressors such as hypoxia also involve the adrenal system<sup><xref ref-type="bibr" rid="bib140">140</xref>, <xref ref-type="bibr" rid="bib141">141</xref></sup> and are essential to fetal survival and neurodevelopment.<sup><xref ref-type="bibr" rid="bib142">142</xref></sup> Whether the maternal microbiome can influence these pathways remains unknown.</p>
<p>The manner in which a hyperactive maternal HPA stress response influences fetal development is unclear; however, an emerging hypothesis involves maternal cortisol crossing the placenta in a quantity sufficient to affect gene expression in fetal brain cells.<sup><xref ref-type="bibr" rid="bib143">143</xref></sup> This model is supported by <italic>in vitro</italic> analysis of human fetal brain aggregates<sup><xref ref-type="bibr" rid="bib144">144</xref></sup> and the observation that the effects of PNS on offspring can be partially mimicked by giving pregnant animals a synthetic glucocorticoid or adrenocorticotropic hormone.<sup><xref ref-type="bibr" rid="bib130">130</xref>, <xref ref-type="bibr" rid="bib145">145</xref></sup> However, the interaction of the HPA axis with the maternal microbiome is likely to be complex. In addition to affecting fetal neurodevelopment directly, stress-induced alterations to the HPA axis trigger maternal gut dysbiosis.<sup><xref ref-type="bibr" rid="bib146">146</xref></sup> These changes in the gut microbiota could further influence HPA axis dysfunction through altered tryptophan metabolism, as well as contributing to other dysbiosis-associated dysregulatory pathways.<sup><xref ref-type="bibr" rid="bib94">94</xref></sup> In addition, there is evidence that the gut microbiome influences the function of the placenta via the HPA axis, thereby altering fetal exposure to specific compounds in maternal circulation.<sup><xref ref-type="bibr" rid="bib147">147</xref>, <xref ref-type="bibr" rid="bib148">148</xref>, <xref ref-type="bibr" rid="bib149">149</xref>, <xref ref-type="bibr" rid="bib150">150</xref></sup></p>
<p>The maternal gut microbiota could also affect fetal neurodevelopment by influencing levels of circulating 5-hydroxytryptamine (5-HT). The gut microbiome regulates 5-HT biosynthesis by enterochromaffin (EC) cells in the gut.<sup><xref ref-type="bibr" rid="bib13">13</xref></sup> In turn, 5-HT regulates fetal neuronal cell division, differentiation and synaptogenesis<sup><xref ref-type="bibr" rid="bib151">151</xref></sup> and its depletion results in altered brain development.<sup><xref ref-type="bibr" rid="bib152">152</xref></sup> Furthermore, maternal plasma serotonin is required for proper neuronal morphogenesis during developmental stages that precede the appearance of serotonergic neurons, with embryos depending more on maternal plasma serotonin than their own during <italic>in utero</italic> development.<sup><xref ref-type="bibr" rid="bib153">153</xref></sup> Maternal gut dysbiosis is also likely to influence blood–brain barrier (BBB) formation, a critical component in CNS development, ensuring an optimal microenvironment for neuronal growth and specification.<sup><xref ref-type="bibr" rid="bib154">154</xref></sup> This is suggested by analysis of the embryos of GF mice, where the BBB has been shown to be substantially compromised.<sup><xref ref-type="bibr" rid="bib155">155</xref></sup></p>
</sec>
<sec>
<title>Postnatal neurodevelopment</title>
<p>Neurodevelopment continues outside the womb with the neonatal period characterized by substantial neurological development, including morphological changes, cell differentiation and acquisition of function.<sup><xref ref-type="bibr" rid="bib156">156</xref>, <xref ref-type="bibr" rid="bib157">157</xref></sup> Synaptogenesis begins shortly after birth and reaches maximum levels by around 2 years of age, before a process of synaptic refinement and elimination reduces the number of synapses in the postnatal brain to adult levels by mid-adolescence.<sup><xref ref-type="bibr" rid="bib158">158</xref></sup> Remodelling continues well into the third decade of life,<sup><xref ref-type="bibr" rid="bib159">159</xref></sup> providing a lengthy window of vulnerability to external perturbations. This critical period of neurodevelopment parallels the establishment and maturation of the microbiome, a process now known to be essential for the establishment of normal immune function,<sup><xref ref-type="bibr" rid="bib160">160</xref>, <xref ref-type="bibr" rid="bib161">161</xref>, <xref ref-type="bibr" rid="bib162">162</xref>, <xref ref-type="bibr" rid="bib163">163</xref>, <xref ref-type="bibr" rid="bib164">164</xref></sup> the neuroendocrine system<sup><xref ref-type="bibr" rid="bib165">165</xref></sup> and metabolic regulation.<sup><xref ref-type="bibr" rid="bib166">166</xref>, <xref ref-type="bibr" rid="bib167">167</xref></sup> Disruption of the microbiome in early life therefore has the potential to influence neurodevelopment and long-term mental health outcomes, particularly through its interaction with the immune system and the gut–brain axis.</p>
<p>Gnotobiotic animal models have been important in demonstrating the contribution of the developing microbiome to early-life neurodevelopment and the establishment of appropriate stress responses. For example, GF mice have an exaggerated hypothalamic-pituitary response to mild restraint stress, with elevated plasma adrenocorticotropic hormone and corticosterone and reduced BDNF expression levels in the cortex and hippocampus.<sup><xref ref-type="bibr" rid="bib49">49</xref></sup> Furthermore, mice that develop in the absence of microbes exhibit increased motor activity and reduced anxiety, associated with differential expression of synaptophysin and PSD-95, proteins that are specifically involved in synaptogenesis pathways.<sup><xref ref-type="bibr" rid="bib48">48</xref></sup> Microbial colonization is also required for programming and presentation of normal social behaviours, and is important for the regulation of repetitive behaviours,<sup><xref ref-type="bibr" rid="bib168">168</xref></sup> the development of non-spatial memory,<sup><xref ref-type="bibr" rid="bib29">29</xref></sup> and the development of pain signalling from the body.<sup><xref ref-type="bibr" rid="bib169">169</xref></sup> It is important to note that the absence of appropriate microbial developmental cues in early-life can result in aberrant mental development that is not corrected by later microbial exposure (Neufeld <italic>et al.</italic>).<sup><xref ref-type="bibr" rid="bib170">170</xref></sup></p>
<p>It is clear from these and other GF animal studies that the absence of a commensal microbiota during early-life substantially affects both neurophysiology and the risk of abnormal behaviour development. However, while a useful tool for highlighting mechanistic pathways, the GF animal poorly reflects the types of microbiome disruption that may occur in humans. As such, other investigations have attempted to recreate real-world early-life insults in the controlled context of animal models. For example, while associations between caesarean-section delivery, altered early life microbial colonization<sup><xref ref-type="bibr" rid="bib171">171</xref>, <xref ref-type="bibr" rid="bib172">172</xref></sup> and the incidence of behavioural disorders and abnormal cognitive development in humans<sup><xref ref-type="bibr" rid="bib173">173</xref>, <xref ref-type="bibr" rid="bib174">174</xref>, <xref ref-type="bibr" rid="bib175">175</xref></sup> have been known for some time, the extent to which a direct causal relationship exists is difficult to discern, given the number of other potentially contributing variables. However, when vaginally delivered mouse pups are compared with those delivered via caesarean section they show an altered gut microbiome and increased anxiety, social deficits and repetitive behaviours reminiscent of autism spectrum disorder-like behaviours in humans.<sup><xref ref-type="bibr" rid="bib176">176</xref></sup></p>
<p>Even in animal models though, the line between pre- and post-delivery periods is blurred by factors such as the vertical transmission of microbiota, the influence of the maternal microbiome of milk composition,<sup><xref ref-type="bibr" rid="bib177">177</xref></sup> and the continuation of stressors in the external environment. An example of this complexity is the impact of PNS on neurodevelopment. PNS has been shown to alter the composition of the gut<sup><xref ref-type="bibr" rid="bib178">178</xref></sup> and maternal vaginal microbiota in mice,<sup><xref ref-type="bibr" rid="bib98">98</xref>, <xref ref-type="bibr" rid="bib179">179</xref></sup> thereby altering the pool of microbes that can be passed to the neonate (an analogous situation has been described in humans, where PNS has been shown to affect the composition of the human infant gut microbiota over the first 110 days after birth<sup><xref ref-type="bibr" rid="bib180">180</xref></sup>). As above although PNS also alters prenatal development, and therefore the nature of interactions between the neonate and microbes in early life. Determining the relative contribution and timing of contributory pathways to long-term psychopathological outcomes is therefore challenging.</p>
<p>The lasting impact of antibiotic exposure on the microbiome, whether during pregnancy,<sup><xref ref-type="bibr" rid="bib181">181</xref>, <xref ref-type="bibr" rid="bib182">182</xref></sup> intrapartum<sup><xref ref-type="bibr" rid="bib183">183</xref></sup> or in the neonatal period<sup><xref ref-type="bibr" rid="bib24">24</xref>, <xref ref-type="bibr" rid="bib184">184</xref></sup> is an example of a further complex factor. There is clear potential for antibiotic dysbiosis to contribute to maternally mediated antenatal neurodevelopment, while antibiotic dysbiosis is also heritable.<sup><xref ref-type="bibr" rid="bib25">25</xref></sup> Early-life exposure to antibiotics has been shown to result in long-term immune dysregulation<sup><xref ref-type="bibr" rid="bib185">185</xref></sup> and visceral hypersensitivity.<sup><xref ref-type="bibr" rid="bib186">186</xref></sup> Further, the developmental impact of antibiotic dysbiosis is not limited to the neonatal period, with adolescent rats exhibiting an altered tryptophan metabolic pathway, reduced anxiety and cognitive defects.<sup><xref ref-type="bibr" rid="bib187">187</xref></sup></p>
<p>Diet-induced maternal dysbiosis may also affect early-life neurodevelopment through milk composition. For example, the offspring of mice fed an HFD during lactation show developmental and neurobehavioral changes that suggest possible disruption of physical and sensory-motor maturation, and increased susceptibility to depressive and aggressive-like behaviour.<sup><xref ref-type="bibr" rid="bib188">188</xref></sup> These observations suggests further work in in relation to dietary inputs will be important in understanding brain function determinants in humans.</p>
</sec>
</sec>
<sec>
<title>Mechanisms of interaction</title>
<p>Activation of inflammatory pathways appears to be a particularly important link between the microbiome and neonatal neurodevelopment. The gut microbiota can affect the immune system directly via activation of the vagus nerve,<sup><xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib126">126</xref>, <xref ref-type="bibr" rid="bib189">189</xref>, <xref ref-type="bibr" rid="bib190">190</xref>, <xref ref-type="bibr" rid="bib191">191</xref></sup> in turn triggering bidirectional communication with the CNS.<sup><xref ref-type="bibr" rid="bib192">192</xref></sup> In addition, indirect effects of the gut microbiota on the innate immune system can result in alterations in the circulating levels of pro- and anti-inflammatory cytokines that directly affect brain function.</p>
<p>Bacterial metabolites from the gut have a substantial influence on the regulation of the gut–brain axis and local and systemic immunity. SCFAs, produced by the bacterial fermentation of dietary carbohydrates, have immunomodulatory properties<sup><xref ref-type="bibr" rid="bib121">121</xref>, <xref ref-type="bibr" rid="bib123">123</xref>, <xref ref-type="bibr" rid="bib124">124</xref>, <xref ref-type="bibr" rid="bib193">193</xref></sup> and can interact with nerve cells by stimulating the sympathetic and autonomic nervous system via G-protein-coupled (GPR) receptor 41 (GPR41)<sup><xref ref-type="bibr" rid="bib194">194</xref></sup> and GPR43.<sup><xref ref-type="bibr" rid="bib195">195</xref></sup> In addition, they can cross the BBB, modulate brain development and behaviour<sup><xref ref-type="bibr" rid="bib196">196</xref>, <xref ref-type="bibr" rid="bib197">197</xref>, <xref ref-type="bibr" rid="bib198">198</xref></sup> and have been implicated in the development of autism.<sup><xref ref-type="bibr" rid="bib199">199</xref></sup> Further, gut microbiota derived SCFAs have been shown to regulate microglia homoeostasis,<sup><xref ref-type="bibr" rid="bib200">200</xref></sup> necessary for proper brain development and brain tissue homoeostasis.<sup><xref ref-type="bibr" rid="bib201">201</xref>, <xref ref-type="bibr" rid="bib202">202</xref>, <xref ref-type="bibr" rid="bib203">203</xref></sup> GF mice display global defects in microglia with altered cell proportions and an immature phenotype, leading to impaired innate immune responses in the CNS.<sup><xref ref-type="bibr" rid="bib200">200</xref></sup> SCFAs also regulate the release of gut peptides from enteroendocrine cells,<sup><xref ref-type="bibr" rid="bib204">204</xref></sup> which in turn affect gut–brain hormonal communication.<sup><xref ref-type="bibr" rid="bib205">205</xref>, <xref ref-type="bibr" rid="bib206">206</xref></sup> SCFAs have recently been shown to regulate the synthesis of gut-derived 5-HT from EC cells.<sup><xref ref-type="bibr" rid="bib13">13</xref></sup> The gut provides ~95% of total body 5-HT,<sup><xref ref-type="bibr" rid="bib207">207</xref></sup> most of which exists in plasma. Although this source of 5-HT has intrinsic roles within the gut<sup><xref ref-type="bibr" rid="bib208">208</xref>, <xref ref-type="bibr" rid="bib209">209</xref></sup> and peripherally in metabolic control,<sup><xref ref-type="bibr" rid="bib210">210</xref></sup> EC cell 5-HT can activate afferent nerve endings to signal to the CNS.<sup><xref ref-type="bibr" rid="bib211">211</xref></sup> Furthermore, this source of 5-HT has significant links to psychiatric disorders with the most commonly used antidepressant, fluoxetine, blocking the transport of gut 5-HT into plasma, while elevated plasma serotonin is observed in 25–50% of children with autism<sup><xref ref-type="bibr" rid="bib212">212</xref>, <xref ref-type="bibr" rid="bib213">213</xref>, <xref ref-type="bibr" rid="bib214">214</xref>, <xref ref-type="bibr" rid="bib215">215</xref></sup> and an inverse correlation between high plasma serotonin and low serotonergic neurotransmission has been demonstrated in young male adults with autism spectrum disorder.<sup><xref ref-type="bibr" rid="bib216">216</xref></sup> In addition to SCFAs, gut bacteria are also capable of producing an array of other neuroactive and immunomodulatory compounds, including dopamine,<sup><xref ref-type="bibr" rid="bib217">217</xref></sup> γ-aminobutyric acid,<sup><xref ref-type="bibr" rid="bib218">218</xref></sup> histamine<sup><xref ref-type="bibr" rid="bib219">219</xref></sup> and acetylcholine,<sup><xref ref-type="bibr" rid="bib220">220</xref></sup> while the gut microbiome is an important regulator of bile acid pool size and composition,<sup><xref ref-type="bibr" rid="bib221">221</xref></sup> and, in turn, BBB integrity and HPA function.<sup><xref ref-type="bibr" rid="bib222">222</xref></sup></p>
<p>The gut microbiota could also contribute to the regulation of brain function by influencing tryptophan metabolism (reviewed by O'Mahony and colleagues<sup><xref ref-type="bibr" rid="bib95">95</xref></sup>). Tryptophan is an essential, diet-derived, amino acid,<sup><xref ref-type="bibr" rid="bib223">223</xref></sup> required for serotonin synthesis in the CNS.<sup><xref ref-type="bibr" rid="bib224">224</xref></sup> Once absorbed from the gut, tryptophan can cross the BBB and participate in serotonin synthesis.<sup><xref ref-type="bibr" rid="bib224">224</xref></sup> However, there are many other pathways through which tryptophan can be metabolized,<sup><xref ref-type="bibr" rid="bib224">224</xref></sup> including the largely hepatic kynurenine pathway<sup><xref ref-type="bibr" rid="bib225">225</xref></sup> and the major serotonin synthesis pathway in gut EC cells.<sup><xref ref-type="bibr" rid="bib226">226</xref>, <xref ref-type="bibr" rid="bib227">227</xref>, <xref ref-type="bibr" rid="bib228">228</xref></sup></p>
<p>The availability of tryptophan is heavily influenced by the gut microbiota. GF mice have been shown to have increased plasma tryptophan concentrations,<sup><xref ref-type="bibr" rid="bib47">47</xref>, <xref ref-type="bibr" rid="bib48">48</xref></sup> which can be normalized following post-weaning colonization.<sup><xref ref-type="bibr" rid="bib47">47</xref></sup> Resident gut bacteria can utilize tryptophan for growth<sup><xref ref-type="bibr" rid="bib229">229</xref></sup> and in some cases, production of indole,<sup><xref ref-type="bibr" rid="bib230">230</xref>, <xref ref-type="bibr" rid="bib231">231</xref></sup> or serotonin (reviewed by O'Mahony and colleagues<sup><xref ref-type="bibr" rid="bib95">95</xref></sup>), while the microbiota might also affect tryptophan availability by influencing host enzymes responsible for its degradation.<sup><xref ref-type="bibr" rid="bib47">47</xref></sup> By limiting the availability of tryptophan for serotonin production in the CNS (EC-derived serotonin does not cross the BBB), the gut microbiota could influence serotonergic neurotransmission.<sup><xref ref-type="bibr" rid="bib95">95</xref></sup> In vulnerable populations, reducing the circulating concentrations of tryptophan has been shown to affect mood, and to reinstate depressive symptoms in patients who have successfully responded to selective serotonin reuptake inhibitors.<sup><xref ref-type="bibr" rid="bib232">232</xref>, <xref ref-type="bibr" rid="bib233">233</xref></sup> The gut microbiota could also influence the production of both neuroprotective and neurotoxic components of the kynurenine pathway.<sup><xref ref-type="bibr" rid="bib224">224</xref></sup></p>
<p>Other pathways by which the gut microbiota could influence the development and activity of brain tissue include regulation of the release of gut peptides from enteroendocrine cells,<sup><xref ref-type="bibr" rid="bib204">204</xref></sup> which in turn affect gut–brain hormonal communication,<sup><xref ref-type="bibr" rid="bib205">205</xref>, <xref ref-type="bibr" rid="bib206">206</xref></sup> and, as described above, the regulation of microglia homoeostasis.</p>
<p>Two recent, related papers by Wong <italic>et al.</italic> and Zheng <italic>et al.</italic> indicate that the microbiota–gut–brain axis functions in a bidirectional manner in the regulation of depressive-like behaviours. Data in the paper by Wong <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib234">234</xref></sup> demonstrate that changes in behaviour caused by increased stress levels, knockout of caspase 1 leading to decreased inflammasome function, or pharmacological treatments result in changes in the gut microbiome. The paper by Zheng <italic>et al.</italic> shows three key findings: (i) the absence of gut microbiota in GF mice resulted in decreased immobility time in the forced swimming test relative to conventionally-raised healthy control mice. (ii) From clinical sampling, the gut microbiotic compositions of MDD patients and healthy controls were significantly different from that of MDD patients. (iii) Faecal microbiota transplantation of GF mice with ‘depression microbiota' derived from MDD patients resulted in depression-like behaviours compared with colonization with ‘healthy microbiota' derived from healthy control individuals. Moreover, the concerned authors showed that mice harbouring ‘depression microbiota' primarily exhibited disturbances of microbial genes and host metabolites involved in carbohydrate and amino acid metabolism, indicating that the development of depressive-like behaviours is mediated through the host's metabolism.<sup><xref ref-type="bibr" rid="bib235">235</xref></sup> The combined findings of these two papers suggest that the microbiota–gut–brain axis is fully bidirectional, functioning in a manner through which changes in microbiota affect behaviour, while conversely, changes in behaviour brought about by chronic stress, genetic manipulation, or pharmacological intervention, result in alterations in microbiota composition. Novel approaches to target this bidirectional interface of gut microbiota and depressive-like behaviour may offer novel approaches for the treatment of major depression.</p>
</sec>
<sec>
<title>The role of the microbiome in age-related cognitive decline</title>
<p>Despite fluctuating in response to external influences, the gut microbiota is thought to remain relatively stable during adulthood.<sup><xref ref-type="bibr" rid="bib236">236</xref></sup> However, just as the microbiome has a critical role in the development of the nervous system in the neonate, it also appears to have a substantial influence on CNS degeneration in old age. Aging affects the brain on both cellular and functional levels, and is associated with decline in sensory, motor and higher cognitive functions.<sup><xref ref-type="bibr" rid="bib237">237</xref>, <xref ref-type="bibr" rid="bib238">238</xref>, <xref ref-type="bibr" rid="bib239">239</xref></sup> This period of life is also associated with marked changes in the microbiome.<sup><xref ref-type="bibr" rid="bib240">240</xref>, <xref ref-type="bibr" rid="bib241">241</xref></sup> In keeping with dysbiosis arising from a range of insults, age-related changes in gut microbiota composition appear to involve a reduction in microbial diversity, with an increased relative abundance of Proteobacteria and a reduction in bifidobacteria species, and reduced SCFA production.<sup><xref ref-type="bibr" rid="bib239">239</xref></sup></p>
<p>It has been suggested that the processes of age-related dysbiosis and neurological decline are linked through the former mediating chronic low-grade inflammation as a common basis for a broad spectrum of age-related pathologies, or so-called ‘inflamm-aging'.<sup><xref ref-type="bibr" rid="bib242">242</xref></sup> Inflammation has a substantial role in cognitive decline, not only in the context of normal aging but also in neurological disorders and sporadic Alzheimer's disease.<sup><xref ref-type="bibr" rid="bib243">243</xref></sup> There are a number of ways in which gut dysbiosis could contribute to this process, including direct inflammatory stimulation, the production of pro-inflammatory metabolites, and the loss of immune-regulatory function. In addition, the gut microbiome is essential to the bioavailability of polyphenols, unsaturated fats and antioxidants, all of which may help protect against neuronal and cell aging role under normal circumstances (reviewed by Caraccciolo <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib239">239</xref></sup>). Notably, dysbiosis-associated inflammation is also strongly implicated in obesity and diabetes, both of which have been shown to exacerbate normal cognitive decline.<sup><xref ref-type="bibr" rid="bib244">244</xref>, <xref ref-type="bibr" rid="bib245">245</xref>, <xref ref-type="bibr" rid="bib246">246</xref>, <xref ref-type="bibr" rid="bib247">247</xref></sup></p>
<p>Age-related changes in the brain are most pronounced in the amygdala, hippocampus and frontal cortex,<sup><xref ref-type="bibr" rid="bib248">248</xref></sup> whose function is heavily dependent on serotonergic neurotransmission,<sup><xref ref-type="bibr" rid="bib249">249</xref></sup> potentially implicating microbiome-influenced changes in tryptophan metabolism. Further, altered serotonin systems could represent a common link with changes in sleep, sexual behaviour and mood in the elderly, as well as disorders such as diabetes, faecal incontinence and cardiovascular diseases.<sup><xref ref-type="bibr" rid="bib94">94</xref>, <xref ref-type="bibr" rid="bib250">250</xref></sup></p>
<p>An association between loss of microbiome function, specifically genes that encode SCFAs, and increased levels of circulating pro-inflammatory cytokines, has been shown in healthy elderly people.<sup><xref ref-type="bibr" rid="bib251">251</xref></sup> Further, markers of microbiome change are significantly correlated with diet, and with indices of frailty and poor health among long-term institutionalized people,<sup><xref ref-type="bibr" rid="bib251">251</xref></sup> while feeding cognitively healthy elderly individuals a diet low in meat and meat products is associated with subsequent increases in brain volume and cognitive function.<sup><xref ref-type="bibr" rid="bib252">252</xref></sup> Interestingly, in mice, the same HFD predisposes to physiological and anxiety-like effects in adults, while aged mice display deficits in spatial cognition,<sup><xref ref-type="bibr" rid="bib253">253</xref></sup> suggesting the effect of stressors changes during the aging process.</p>
<p>With a growing appreciation of the healthcare implications of an aging global population<sup><xref ref-type="bibr" rid="bib254">254</xref>, <xref ref-type="bibr" rid="bib255">255</xref>, <xref ref-type="bibr" rid="bib256">256</xref></sup> obtaining a better understanding of how the bidirectional interaction between the microbiome and gut–brain axis that influences age-related changes in brain function, must be a priority.</p>
</sec>
<sec>
<title>Modification of the gut microbiota to affect therapeutic change</title>
<p>As described above, studies in mice have shown that alteration of the microbial composition of the gut can induce changes in behaviour, raising the possibility of therapeutic manipulation of the microbiome. What approach might be appropriate depends on the specific role of the microbiome in pathogenesis.</p>
<p>In instances where the absence of particular bacterial species is linked to altered brain function, the addition of discrete microbes may be clinically effective. For example, in rats deprived of maternal contact at an early age, treatment with <italic>Bifidobacterium infantis</italic> results in normalization of the immune response, reversal of behavioural deficits, and restoration of basal noradrenaline concentrations in the brainstem,<sup><xref ref-type="bibr" rid="bib257">257</xref></sup> while in a mouse model of gastrointestinal inflammation and infection, exposure to <italic>B. longum</italic> normalizes anxiety-like behaviour.<sup><xref ref-type="bibr" rid="bib258">258</xref>, <xref ref-type="bibr" rid="bib259">259</xref></sup> The effects of psychosocial stress are also reversed in mice following probiotic treatments.<sup><xref ref-type="bibr" rid="bib260">260</xref>, <xref ref-type="bibr" rid="bib261">261</xref></sup> Such effects are not limited to rodent models; in healthy women, a probiotic cocktail alters activity of brain regions that control central processing of emotion and sensation.<sup><xref ref-type="bibr" rid="bib262">262</xref></sup> Broadly, such probiotic effects appear to mediate behavioural changes through stimulation of the vagus nerve<sup><xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib191">191</xref>, <xref ref-type="bibr" rid="bib258">258</xref></sup> or through modulation of cytokine production.<sup><xref ref-type="bibr" rid="bib263">263</xref></sup></p>
<p>Probiotic therapies have limitations, including a poor ability to establish a stable population within the recipient. Further, in many instances, pathogenesis may be contributed to by broad functions conserved across many different species, such as the ability to produce metabolites that are immunomodulatory, or that directly influence brain activity.<sup><xref ref-type="bibr" rid="bib264">264</xref>, <xref ref-type="bibr" rid="bib265">265</xref></sup> Here, it may be the absence of suitable drivers of beneficial behaviour that is limiting, rather than the absence of microbes capable of exhibiting them. In such instances, the broad-scale alteration of the microbiome using selective dietary microbial growth substrates, or prebiotics, may be more appropriate and result in longer lasting change. For example, consumption of fructooligosaccharides or a non-digestible galactooligosaccharide formulation (BGOS) elevates BDNF levels and NMDAR subunit expression in rats.<sup><xref ref-type="bibr" rid="bib266">266</xref></sup> BGOS consumption also reduces anxiety in mice injected with lipopolysaccharide to induce sickness behaviour, an effect that appears to be related to the modulation of cortical interleukin-1β and 5-HT<sub>2A</sub> receptor expression.<sup><xref ref-type="bibr" rid="bib267">267</xref></sup> In humans, daily consumption of BGOS for 3 weeks results in a significantly lower salivary cortisol awakening response compared with placebo and a decreased attentional vigilance to negative versus positive information.<sup><xref ref-type="bibr" rid="bib268">268</xref></sup> Pusceddu <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib269">269</xref></sup> showed that long-term supplementation with n-3 polyunsaturated fatty acids corrected dysbiosis seen in maternally separated female rats, and was associated with an attenuation of the corticosterone response to acute stress. Interestingly, while the supporting evidence for the efficacy or such approaches is only now emerging, the consumption of wholegrain and high fibre foods, essentially prebiotics, is already recommended to patients.<sup><xref ref-type="bibr" rid="bib270">270</xref></sup></p>
<p>Demonstrations of the transmissibility of behavioural traits between animals by faecal microbiota transfer are also intriguing. Faecal microbiota transfer is employed increasingly widely in the treatment of conditions such as recurrent <italic>Clostridium difficile</italic> infection.<sup><xref ref-type="bibr" rid="bib271">271</xref></sup> Its ability to influence behaviour suggests that it might also have a role in the treatment of psychopathology (reviewed by Collins <italic>et al.</italic><sup><xref ref-type="bibr" rid="bib272">272</xref></sup>). It is important to note, however, that these observations also raise important questions about current approaches to donor screening for therapeutic faecal microbiota transfer.</p>
</sec>
<sec>
<title>Future directions</title>
<p>The advances in our understanding of the role of the microbiome in neurodevelopment and mental health, particularly in the past 5 years, have been remarkable. The implications of this new insight are only beginning to become apparent; however, the potential value of microbiome analyses in revealing mechanisms that underpin altered brain development and mental illness is hugely exciting. There is now a need to close the gap between practice, including the increasing use of pro- and prebiotics, and the supporting science. The importance of achieving this is reflected in the substantial investments made to ‘microbiome–gut–brain axis' research by both the US government and the European Union.<sup><xref ref-type="bibr" rid="bib273">273</xref></sup></p>
<p>Achieving a better understanding of the contribution of the microbiome to mental health will require further development of analytical approaches. Studies based on reductive animal models, particularly those involving GF animals, have been important in identifying underlying mechanisms; however, they exclude the complexity of real-world interactions. The rapidly falling costs of ‘omics' approaches to microbiome analysis now allow them to be applied to large human cohorts within life-course studies, with data generated assessed in the context of detailed genetic, epigenetic, demographic and clinical assessments. Exploiting these opportunities will result in substantial improvement in our understanding of altered brain function and mental illness in the relative near-term.</p>
<p>In addition to changing analytical strategies, the conceptual framework within which these data are assessed must also continue to develop. A ‘three-hit' model of vulnerability and resilience to mental health issues, based on genetic predisposition, the prenatal environment, and later life experiences, has been proposed.<sup><xref ref-type="bibr" rid="bib274">274</xref></sup> However, just as the gut–brain axis might be extended to include the microbiome, such developmental pathways must also take into consideration points of interaction with our resident microbiota. Refining these models based on empirical data now represents a key challenge in understanding the processes behind altered brain function and mental illness.</p>
</sec>
</body>
<back>
<notes>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<ref id="bib1">
<mixed-citation publication-type="journal">Sternbach H, State R. <article-title>Antibiotics: neuropsychiatric effects and psychotropic interactions</article-title>. <source/>Harv Rev Psychiatry
<year>1997</year>; <volume>5</volume>: <fpage>214</fpage>–226.<pub-id pub-id-type="pmid">9427014</pub-id></mixed-citation>
</ref>
<ref id="bib2">
<mixed-citation publication-type="journal">Bested AC, Logan AC, Selhub EM. <article-title>Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part I - autointoxication revisited</article-title>. <source/>Gut Pathog
<year>2013</year>; <volume>5</volume>: <fpage>5</fpage>.<pub-id pub-id-type="pmid">23506618</pub-id></mixed-citation>
</ref>
<ref id="bib3">
<mixed-citation publication-type="journal">Bested AC, Logan AC, Selhub EM. <article-title>Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part II - contemporary contextual research</article-title>. <source/>Gut Pathog
<year>2013</year>; <volume>5</volume>: <fpage>3</fpage>.<pub-id pub-id-type="pmid">23497633</pub-id></mixed-citation>
</ref>
<ref id="bib4">
<mixed-citation publication-type="journal">Neufeld KA, Foster JA. <article-title>Effects of gut microbiota on the brain: implications for psychiatry</article-title>. <source/>J Psychiatry Neurosci
<year>2009</year>; <volume>34</volume>: <fpage>230</fpage>–231.<pub-id pub-id-type="pmid">19448854</pub-id></mixed-citation>
</ref>
<ref id="bib5">
<mixed-citation publication-type="journal">Kennedy PJ, Cryan JF, Dinan TG, Clarke G. <article-title>Irritable bowel syndrome: a microbiome-gut-brain axis disorder</article-title>? <source/>World J Gastroenterol
<year>2014</year>; <volume>20</volume>: <fpage>14105</fpage>–14125.<pub-id pub-id-type="pmid">25339800</pub-id></mixed-citation>
</ref>
<ref id="bib6">
<mixed-citation publication-type="journal">Whitehead WE, Palsson O, Jones KR. <article-title>Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications</article-title>? <source/>Gastroenterology
<year>2002</year>; <volume>122</volume>: <fpage>1140</fpage>–1156.<pub-id pub-id-type="pmid">11910364</pub-id></mixed-citation>
</ref>
<ref id="bib7">
<mixed-citation publication-type="journal">Grenham S, Clarke G, Cryan JF, Dinan TG. <article-title>Brain-gut-microbe communication in health and disease</article-title>. <source/>Front Physiol
<year>2011</year>; <volume>2</volume>: <fpage>94</fpage>.<pub-id pub-id-type="pmid">22162969</pub-id></mixed-citation>
</ref>
<ref id="bib8">
<mixed-citation publication-type="journal">Mayer EA, Tillisch K. <article-title>The brain-gut axis in abdominal pain syndromes</article-title>. <source/>Annu Rev Med
<year>2011</year>; <volume>62</volume>: <fpage>381</fpage>–396.<pub-id pub-id-type="pmid">21090962</pub-id></mixed-citation>
</ref>
<ref id="bib9">
<mixed-citation publication-type="journal">Cryan JF, Dinan TG. <article-title>Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour</article-title>. <source/>Nat Rev Neurosci
<year>2012</year>; <volume>13</volume>: <fpage>701</fpage>–712.<pub-id pub-id-type="pmid">22968153</pub-id></mixed-citation>
</ref>
<ref id="bib10">
<mixed-citation publication-type="journal">Collins SM, Surette M, Bercik P. <article-title>The interplay between the intestinal microbiota and the brain</article-title>. <source/>Nat Rev Microbiol
<year>2012</year>; <volume>10</volume>: <fpage>735</fpage>–742.<pub-id pub-id-type="pmid">23000955</pub-id></mixed-citation>
</ref>
<ref id="bib11">
<mixed-citation publication-type="journal">Foster JA, McVey Neufeld KA. <article-title>Gut-brain axis: how the microbiome influences anxiety and depression</article-title>. <source/>Trends Neurosci
<year>2013</year>; <volume>36</volume>: <fpage>305</fpage>–312.<pub-id pub-id-type="pmid">23384445</pub-id></mixed-citation>
</ref>
<ref id="bib12">
<mixed-citation publication-type="journal">Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley EM. <article-title>Gut microbiota and gastrointestinal health: current concepts and future directions</article-title>. <source/>Neurogastroenterol Motil
<year>2013</year>; <volume>25</volume>: <fpage>4</fpage>–15.<pub-id pub-id-type="pmid">23279728</pub-id></mixed-citation>
</ref>
<ref id="bib13">
<mixed-citation publication-type="journal">Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L et al. <article-title>Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis</article-title>. <source/>Cell
<year>2015</year>; <volume>161</volume>: <fpage>264</fpage>–276.<pub-id pub-id-type="pmid">25860609</pub-id></mixed-citation>
</ref>
<ref id="bib14">
<mixed-citation publication-type="journal">Crane JD, Palanivel R, Mottillo EP, Bujak AL, Wang H, Ford RJ et al. <article-title>Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis</article-title>. <source/>Nat Med
<year>2015</year>; <volume>21</volume>: <fpage>166</fpage>–172.<pub-id pub-id-type="pmid">25485911</pub-id></mixed-citation>
</ref>
<ref id="bib15">
<mixed-citation publication-type="journal">Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A, Dekens JA et al. <article-title>The gut microbiome contributes to a substantial proportion of the variation in blood lipids</article-title>. <source/>Circ Res
<year>2015</year>; <volume>117</volume>: <fpage>817</fpage>–824.<pub-id pub-id-type="pmid">26358192</pub-id></mixed-citation>
</ref>
<ref id="bib16">
<mixed-citation publication-type="journal">Valentini M, Piermattei A, Di Sante G, Migliara G, Delogu G, Ria F. <article-title>Immunomodulation by gut microbiota: role of Toll-like receptor expressed by T cells</article-title>. <source/>J Immunol Res
<year>2014</year>; <volume>2014</volume>: <fpage>586939</fpage>.<pub-id pub-id-type="pmid">25147831</pub-id></mixed-citation>
</ref>
<ref id="bib17">
<mixed-citation publication-type="journal">Sorini C, Falcone M. <article-title>Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes</article-title>. <source/>Am J Clin Exp Immunol
<year>2013</year>; <volume>2</volume>: <fpage>156</fpage>–171.<pub-id pub-id-type="pmid">23885333</pub-id></mixed-citation>
</ref>
<ref id="bib18">
<mixed-citation publication-type="journal">Dinan TG, Cryan JF. <article-title>Melancholic microbes: a link between gut microbiota and depression</article-title>? <source/>Neurogastroenterol Motil
<year>2013</year>; <volume>25</volume>: <fpage>713</fpage>–719.<pub-id pub-id-type="pmid">23910373</pub-id></mixed-citation>
</ref>
<ref id="bib19">
<mixed-citation publication-type="journal">Cryan JF, O'Mahony SM. <article-title>The microbiome-gut-brain axis: from bowel to behavior</article-title>. <source/>Neurogastroenterol Motil
<year>2011</year>; <volume>23</volume>: <fpage>187</fpage>–192.<pub-id pub-id-type="pmid">21303428</pub-id></mixed-citation>
</ref>
<ref id="bib20">
<mixed-citation publication-type="journal">Collins SM, Bercik P. <article-title>The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease</article-title>. <source/>Gastroenterology
<year>2009</year>; <volume>136</volume>: <fpage>2003</fpage>–2014.<pub-id pub-id-type="pmid">19457424</pub-id></mixed-citation>
</ref>
<ref id="bib21">
<mixed-citation publication-type="journal">Rhee SH, Pothoulakis C, Mayer EA. <article-title>Principles and clinical implications of the brain-gut-enteric microbiota axis</article-title>. <source/>Nat Rev Gastroenterol Hepatol
<year>2009</year>; <volume>6</volume>: <fpage>306</fpage>–314.<pub-id pub-id-type="pmid">19404271</pub-id></mixed-citation>
</ref>
<ref id="bib22">
<mixed-citation publication-type="journal">Bravo JA, Julio-Pieper M, Forsythe P, Kunze W, Dinan TG, Bienenstock J et al. <article-title>Communication between gastrointestinal bacteria and the nervous system</article-title>. <source/>Curr Opin Pharmacol
<year>2012</year>; <volume>12</volume>: <fpage>667</fpage>–672.<pub-id pub-id-type="pmid">23041079</pub-id></mixed-citation>
</ref>
<ref id="bib23">
<mixed-citation publication-type="journal">Gohir W, Whelan FJ, Surette MG, Moore C, Schertzer JD, Sloboda DM. <article-title>Pregnancy-related changes in the maternal gut microbiota are dependent upon the mother's periconceptional diet</article-title>. <source/>Gut Microbes
<year>2015</year>; <volume>6</volume>: <fpage>310</fpage>–320.<pub-id pub-id-type="pmid">26322500</pub-id></mixed-citation>
</ref>
<ref id="bib24">
<mixed-citation publication-type="journal">Russell SL, Gold MJ, Hartmann M, Willing BP, Thorson L, Wlodarska M et al. <article-title>Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma</article-title>. <source/>EMBO Rep
<year>2012</year>; <volume>13</volume>: <fpage>440</fpage>–447.<pub-id pub-id-type="pmid">22422004</pub-id></mixed-citation>
</ref>
<ref id="bib25">
<mixed-citation publication-type="journal">Ma J, Prince AL, Bader D, Hu M, Ganu R, Baquero K et al. <article-title>High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model</article-title>. <source/>Nat Commun
<year>2014</year>; <volume>5</volume>: <fpage>3889</fpage>.<pub-id pub-id-type="pmid">24846660</pub-id></mixed-citation>
</ref>
<ref id="bib26">
<mixed-citation publication-type="journal">Thaiss CA, Zeevi D, Levy M, Zilberman-Schapira G, Suez J, Tengeler AC et al. <article-title>Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis</article-title>. <source/>Cell
<year>2014</year>; <volume>159</volume>: <fpage>514</fpage>–529.<pub-id pub-id-type="pmid">25417104</pub-id></mixed-citation>
</ref>
<ref id="bib27">
<mixed-citation publication-type="journal">Lurie I, Yang YX, Haynes K, Mamtani R, Boursi B. <article-title>Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study</article-title>. <source/>J Clin Psychiatry
<year>2015</year>; <volume>76</volume>: <fpage>1522</fpage>–1528.<pub-id pub-id-type="pmid">26580313</pub-id></mixed-citation>
</ref>
<ref id="bib28">
<mixed-citation publication-type="journal">Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J et al. <article-title>The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice</article-title>. <source/>Gastroenterology
<year>2011</year>; <volume>141</volume>: <fpage>599</fpage>–609.e1–3.<pub-id pub-id-type="pmid">21683077</pub-id></mixed-citation>
</ref>
<ref id="bib29">
<mixed-citation publication-type="journal">Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ et al. <article-title>Bacterial infection causes stress-induced memory dysfunction in mice</article-title>. <source/>Gut
<year>2011</year>; <volume>60</volume>: <fpage>307</fpage>–317.<pub-id pub-id-type="pmid">20966022</pub-id></mixed-citation>
</ref>
<ref id="bib30">
<mixed-citation publication-type="journal">Liu Z, Patil IY, Jiang T, Sancheti H, Walsh JP, Stiles BL et al. <article-title>High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity</article-title>. <source/>PLoS One
<year>2015</year>; <volume>10</volume>: <fpage>e0128274</fpage>.<pub-id pub-id-type="pmid">26023930</pub-id></mixed-citation>
</ref>
<ref id="bib31">
<mixed-citation publication-type="journal">Daniel H, Moghaddas Gholami A, Berry D, Desmarchelier C, Hahne H, Loh G et al. <article-title>High-fat diet alters gut microbiota physiology in mice</article-title>. <source/>ISME J
<year>2014</year>; <volume>8</volume>: <fpage>295</fpage>–308.<pub-id pub-id-type="pmid">24030595</pub-id></mixed-citation>
</ref>
<ref id="bib32">
<mixed-citation publication-type="journal">Sharma S, Fernandes MF, Fulton S. <article-title>Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal</article-title>. <source/>Int J Obes (Lond)
<year>2013</year>; <volume>37</volume>: <fpage>1183</fpage>–1191.<pub-id pub-id-type="pmid">23229740</pub-id></mixed-citation>
</ref>
<ref id="bib33">
<mixed-citation publication-type="journal">Magnusson KR, Hauck L, Jeffrey BM, Elias V, Humphrey A, Nath R et al. <article-title>Relationships between diet-related changes in the gut microbiome and cognitive flexibility</article-title>. <source/>Neuroscience
<year>2015</year>; <volume>300</volume>: <fpage>128</fpage>–140.<pub-id pub-id-type="pmid">25982560</pub-id></mixed-citation>
</ref>
<ref id="bib34">
<mixed-citation publication-type="journal">Kaptan Z, Akgün-Dar K, Kapucu A, Dedeakayoğulları H, Batu Ş, Üzüm G. <article-title>Long term consequences on spatial learning-memory of low-calorie diet during adolescence in female rats; hippocampal and prefrontal cortex BDNF level, expression of NeuN and cell proliferation in dentate gyrus</article-title>. <source/>Brain Res
<year>2015</year>; <volume>1618</volume>: <fpage>194</fpage>–204.<pub-id pub-id-type="pmid">26072462</pub-id></mixed-citation>
</ref>
<ref id="bib35">
<mixed-citation publication-type="journal">Li W, Dowd SE, Scurlock B, Acosta-Martinez V, Lyte M. <article-title>Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria</article-title>. <source/>Physiol Behav
<year>2009</year>; <volume>96</volume>: <fpage>557</fpage>–567.<pub-id pub-id-type="pmid">19135464</pub-id></mixed-citation>
</ref>
<ref id="bib36">
<mixed-citation publication-type="journal">Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G et al. <article-title>Richness of human gut microbiome correlates with metabolic markers</article-title>. <source/>Nature
<year>2013</year>; <volume>500</volume>: <fpage>541</fpage>–546.<pub-id pub-id-type="pmid">23985870</pub-id></mixed-citation>
</ref>
<ref id="bib37">
<mixed-citation publication-type="journal">Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E et al. <article-title>Dietary intervention impact on gut microbial gene richness</article-title>. <source/>Nature
<year>2013</year>; <volume>500</volume>: <fpage>585</fpage>–588.<pub-id pub-id-type="pmid">23985875</pub-id></mixed-citation>
</ref>
<ref id="bib38">
<mixed-citation publication-type="journal">Bruce-Keller AJ, Salbaum JM, Luo M, Blanchard E 4th, Taylor CM, Welsh DA et al. <article-title>Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity</article-title>. <source/>Biol Psychiatry
<year>2015</year>; <volume>77</volume>: <fpage>607</fpage>–615.<pub-id pub-id-type="pmid">25173628</pub-id></mixed-citation>
</ref>
<ref id="bib39">
<mixed-citation publication-type="journal">Engen PA, Green SJ, Voigt RM, Forsyth CB, Keshavarzian A. <article-title>The gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota</article-title>. <source/>Alcohol Res
<year>2015</year>; <volume>37</volume>: <fpage>223</fpage>–236.<pub-id pub-id-type="pmid">26695747</pub-id></mixed-citation>
</ref>
<ref id="bib40">
<mixed-citation publication-type="journal">Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, Liu Y et al. <article-title>Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of <italic>Lactobacillus rhamnosus</italic> GG treatment</article-title>. <source/>PLoS One
<year>2013</year>; <volume>8</volume>: <fpage>e53028</fpage>.<pub-id pub-id-type="pmid">23326376</pub-id></mixed-citation>
</ref>
<ref id="bib41">
<mixed-citation publication-type="journal">Biedermann L, Zeitz J, Mwinyi J, Sutter-Minder E, Rehman A, Ott SJ et al. <article-title>Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans</article-title>. <source/>PLoS One
<year>2013</year>; <volume>8</volume>: <fpage>e59260</fpage>.<pub-id pub-id-type="pmid">23516617</pub-id></mixed-citation>
</ref>
<ref id="bib42">
<mixed-citation publication-type="journal">Fond G, Boukouaci W, Chevalier G, Regnault A, Eberl G, Hamdani N et al. <article-title>The "psychomicrobiotic": targeting microbiota in major psychiatric disorders: a systematic review</article-title>. <source/>Pathol Biol (Paris)
<year>2015</year>; <volume>63</volume>: <fpage>35</fpage>–42.<pub-id pub-id-type="pmid">25468489</pub-id></mixed-citation>
</ref>
<ref id="bib43">
<mixed-citation publication-type="journal">Castro-Nallar E, Bendall ML, Pérez-Losada M, Sabuncyan S, Severance EG, Dickerson FB et al. <article-title>Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls</article-title>. <source/>PeerJ
<year>2015</year>; <volume>3</volume>: <fpage>e1140</fpage>.<pub-id pub-id-type="pmid">26336637</pub-id></mixed-citation>
</ref>
<ref id="bib44">
<mixed-citation publication-type="journal">Nemani K, Hosseini Ghomi R, McCormick B, Fan X. <article-title>Schizophrenia and the gut-brain axis</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry
<year>2015</year>; <volume>56</volume>: <fpage>155</fpage>–160.<pub-id pub-id-type="pmid">25240858</pub-id></mixed-citation>
</ref>
<ref id="bib45">
<mixed-citation publication-type="journal">Evrensel A, Ceylan ME. <article-title>The gut-brain axis: the missing link in depression</article-title>. <source/>Clin Psychopharmacol Neurosci
<year>2015</year>; <volume>13</volume>: <fpage>239</fpage>–244.<pub-id pub-id-type="pmid">26598580</pub-id></mixed-citation>
</ref>
<ref id="bib46">
<mixed-citation publication-type="journal">O'Brien SM, Scott LV, Dinan TG. <article-title>Cytokines: abnormalities in major depression and implications for pharmacological treatment</article-title>. <source/>Hum Psychopharmacol
<year>2004</year>; <volume>19</volume>: <fpage>397</fpage>–403.<pub-id pub-id-type="pmid">15303243</pub-id></mixed-citation>
</ref>
<ref id="bib47">
<mixed-citation publication-type="journal">Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F et al. <article-title>The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner</article-title>. <source/>Mol Psychiatry
<year>2013</year>; <volume>18</volume>: <fpage>666</fpage>–673.<pub-id pub-id-type="pmid">22688187</pub-id></mixed-citation>
</ref>
<ref id="bib48">
<mixed-citation publication-type="journal">Diaz Heijtz R, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A et al. <article-title>Normal gut microbiota modulates brain development and behavior</article-title>. <source/>Proc Natl Acad Sci USA
<year>2011</year>; <volume>108</volume>: <fpage>3047</fpage>–3052.<pub-id pub-id-type="pmid">21282636</pub-id></mixed-citation>
</ref>
<ref id="bib49">
<mixed-citation publication-type="journal">Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN et al. <article-title>Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice</article-title>. <source/>J Physiol
<year>2004</year>; <volume>558</volume>: <fpage>263</fpage>–275.<pub-id pub-id-type="pmid">15133062</pub-id></mixed-citation>
</ref>
<ref id="bib50">
<mixed-citation publication-type="journal">Neufeld KM, Kang N, Bienenstock J, Foster JA. <article-title>Reduced anxiety-like behavior and central neurochemical change in germ-free mice</article-title>. <source/>Neurogastroenterol Motil
<year>2011</year>; <volume>23</volume>: <fpage>255</fpage>–264, e119.<pub-id pub-id-type="pmid">21054680</pub-id></mixed-citation>
</ref>
<ref id="bib51">
<mixed-citation publication-type="journal">Maes M, Kubera M, Leunis JC. <article-title>The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression</article-title>. <source/>Neuro Endocrinol Lett
<year>2008</year>; <volume>29</volume>: <fpage>117</fpage>–124.<pub-id pub-id-type="pmid">18283240</pub-id></mixed-citation>
</ref>
<ref id="bib52">
<mixed-citation publication-type="journal">Ait-Belgnaoui A, Bradesi S, Fioramonti J, Theodorou V, Bueno L. <article-title>Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase</article-title>. <source/>Pain
<year>2005</year>; <volume>113</volume>: <fpage>141</fpage>–147.<pub-id pub-id-type="pmid">15621374</pub-id></mixed-citation>
</ref>
<ref id="bib53">
<mixed-citation publication-type="journal">Park AJ, Collins J, Blennerhassett PA, Ghia JE, Verdu EF, Bercik P et al. <article-title>Altered colonic function and microbiota profile in a mouse model of chronic depression</article-title>. <source/>Neurogastroenterol Motil
<year>2013</year>; <volume>25</volume>: <fpage>733</fpage>–e575.<pub-id pub-id-type="pmid">23773726</pub-id></mixed-citation>
</ref>
<ref id="bib54">
<mixed-citation publication-type="journal">Hubbard TD, Murray IA, Bisson WH, Lahoti TS, Gowda K, Amin SG et al. <article-title>Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles</article-title>. <source/>Sci Rep
<year>2015</year>; <volume>5</volume>: <fpage>12689</fpage>.<pub-id pub-id-type="pmid">26235394</pub-id></mixed-citation>
</ref>
<ref id="bib55">
<mixed-citation publication-type="journal">Marcobal A, Kashyap PC, Nelson TA, Aronov PA, Donia MS, Spormann A et al. <article-title>A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice</article-title>. <source/>ISME J
<year>2013</year>; <volume>7</volume>: <fpage>1933</fpage>–1943.<pub-id pub-id-type="pmid">23739052</pub-id></mixed-citation>
</ref>
<ref id="bib56">
<mixed-citation publication-type="journal">Dinan TG, Borre YE, Cryan JF. <article-title>Genomics of schizophrenia: time to consider the gut microbiome</article-title>? <source/>Mol Psychiatry
<year>2014</year>; <volume>19</volume>: <fpage>1252</fpage>–1257.<pub-id pub-id-type="pmid">25288135</pub-id></mixed-citation>
</ref>
<ref id="bib57">
<mixed-citation publication-type="journal">Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D et al. <article-title>Common variants conferring risk of schizophrenia</article-title>. <source/>Nature
<year>2009</year>; <volume>460</volume>: <fpage>744</fpage>–747.<pub-id pub-id-type="pmid">19571808</pub-id></mixed-citation>
</ref>
<ref id="bib58">
<mixed-citation publication-type="journal">Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N et al. <article-title>Schizophrenia risk from complex variation of complement component 4</article-title>. <source/>Nature
<year>2016</year>; <volume>530</volume>: <fpage>177</fpage>–183.<pub-id pub-id-type="pmid">26814963</pub-id></mixed-citation>
</ref>
<ref id="bib59">
<mixed-citation publication-type="journal">Fan X, Goff DC, Henderson DC. <article-title>Inflammation and schizophrenia</article-title>. <source/>Expert Rev Neurother
<year>2007</year>; <volume>7</volume>: <fpage>789</fpage>–796.<pub-id pub-id-type="pmid">17610386</pub-id></mixed-citation>
</ref>
<ref id="bib60">
<mixed-citation publication-type="journal">Song X, Fan X, Song X, Zhang J, Zhang W, Li X et al. <article-title>Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight</article-title>. <source/>Schizophr Res
<year>2013</year>; <volume>150</volume>: <fpage>269</fpage>–273.<pub-id pub-id-type="pmid">23968860</pub-id></mixed-citation>
</ref>
<ref id="bib61">
<mixed-citation publication-type="journal">Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. <article-title>Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects</article-title>. <source/>Biol Psychiatry
<year>2011</year>; <volume>70</volume>: <fpage>663</fpage>–671.<pub-id pub-id-type="pmid">21641581</pub-id></mixed-citation>
</ref>
<ref id="bib62">
<mixed-citation publication-type="journal">Meyer U, Feldon J. <article-title>Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia</article-title>. <source/>Psychopharmacology (Berl)
<year>2009</year>; <volume>206</volume>: <fpage>587</fpage>–602.<pub-id pub-id-type="pmid">19277608</pub-id></mixed-citation>
</ref>
<ref id="bib63">
<mixed-citation publication-type="journal">Müller N, Myint AM, Schwarz MJ. <article-title>Inflammation in schizophrenia</article-title>. <source/>Adv Protein Chem Struct Biol
<year>2012</year>; <volume>88</volume>: <fpage>49</fpage>–68.<pub-id pub-id-type="pmid">22814706</pub-id></mixed-citation>
</ref>
<ref id="bib64">
<mixed-citation publication-type="journal">Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. <article-title>Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review</article-title>. <source/>Biol Psychiatry
<year>2008</year>; <volume>63</volume>: <fpage>801</fpage>–808.<pub-id pub-id-type="pmid">18005941</pub-id></mixed-citation>
</ref>
<ref id="bib65">
<mixed-citation publication-type="journal">Drexhage RC, Hoogenboezem TA, Cohen D, Versnel MA, Nolen WA, van Beveren NJ et al. <article-title>An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces</article-title>. <source/>Int J Neuropsychopharmacol
<year>2011</year>; <volume>14</volume>: <fpage>746</fpage>–755.<pub-id pub-id-type="pmid">21255481</pub-id></mixed-citation>
</ref>
<ref id="bib66">
<mixed-citation publication-type="journal">Francesconi LP, Ceresér KM, Mascarenhas R, Stertz L, Gama CS, Belmonte-de-Abreu P. <article-title>Increased annexin-V and decreased TNF-α serum levels in chronic-medicated patients with schizophrenia</article-title>. <source/>Neurosci Lett
<year>2011</year>; <volume>502</volume>: <fpage>143</fpage>–146.<pub-id pub-id-type="pmid">21741441</pub-id></mixed-citation>
</ref>
<ref id="bib67">
<mixed-citation publication-type="journal">Kunz M, Ceresér KM, Goi PD, Fries GR, Teixeira AL, Fernandes BS et al. <article-title>Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance</article-title>. <source/>Rev Bras Psiquiatr
<year>2011</year>; <volume>33</volume>: <fpage>268</fpage>–274.<pub-id pub-id-type="pmid">21971780</pub-id></mixed-citation>
</ref>
<ref id="bib68">
<mixed-citation publication-type="journal">Pedrini M, Massuda R, Fries GR, de Bittencourt Pasquali MA, Schnorr CE, Moreira JC et al. <article-title>Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity</article-title>. <source/>J Psychiatr Res
<year>2012</year>; <volume>46</volume>: <fpage>819</fpage>–824.<pub-id pub-id-type="pmid">22520512</pub-id></mixed-citation>
</ref>
<ref id="bib69">
<mixed-citation publication-type="journal">Severance EG, Gressitt KL, Stallings CR, Origoni AE, Khushalani S, Leweke FM et al. <article-title>Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia</article-title>. <source/>Schizophr Res
<year>2013</year>; <volume>148</volume>: <fpage>130</fpage>–137.<pub-id pub-id-type="pmid">23746484</pub-id></mixed-citation>
</ref>
<ref id="bib70">
<mixed-citation publication-type="journal">Fan X, Liu EY, Freudenreich O, Park JH, Liu D, Wang J et al. <article-title>Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia</article-title>. <source/>Schizophr Res
<year>2010</year>; <volume>118</volume>: <fpage>211</fpage>–217.<pub-id pub-id-type="pmid">20189773</pub-id></mixed-citation>
</ref>
<ref id="bib71">
<mixed-citation publication-type="journal">Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO et al. <article-title>Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder</article-title>. <source/>Schizophr Res
<year>2013</year>; <volume>145</volume>: <fpage>36</fpage>–42.<pub-id pub-id-type="pmid">23403415</pub-id></mixed-citation>
</ref>
<ref id="bib72">
<mixed-citation publication-type="journal">Na KS, Jung HY, Kim YK. <article-title>The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry
<year>2014</year>; <volume>48</volume>: <fpage>277</fpage>–286.<pub-id pub-id-type="pmid">23123365</pub-id></mixed-citation>
</ref>
<ref id="bib73">
<mixed-citation publication-type="journal">Ribeiro-Santos A, Lucio Teixeira A, Salgado JV. <article-title>Evidence for an immune role on cognition in schizophrenia: a systematic review</article-title>. <source/>Curr Neuropharmacol
<year>2014</year>; <volume>12</volume>: <fpage>273</fpage>–280.<pub-id pub-id-type="pmid">24851091</pub-id></mixed-citation>
</ref>
<ref id="bib74">
<mixed-citation publication-type="journal">Severance EG, Alaedini A, Yang S, Halling M, Gressitt KL, Stallings CR et al. <article-title>Gastrointestinal inflammation and associated immune activation in schizophrenia</article-title>. <source/>Schizophr Res
<year>2012</year>; <volume>138</volume>: <fpage>48</fpage>–53.<pub-id pub-id-type="pmid">22446142</pub-id></mixed-citation>
</ref>
<ref id="bib75">
<mixed-citation publication-type="journal">Douglas-Escobar M, Elliott E, Neu J. <article-title>Effect of intestinal microbial ecology on the developing brain</article-title>. <source/>JAMA Pediatr
<year>2013</year>; <volume>167</volume>: <fpage>374</fpage>–379.<pub-id pub-id-type="pmid">23400224</pub-id></mixed-citation>
</ref>
<ref id="bib76">
<mixed-citation publication-type="journal">Nieto R, Kukuljan M, Silva H. <article-title>BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory</article-title>. <source/>Front Psychiatry
<year>2013</year>; <volume>4</volume>: <fpage>45</fpage>.<pub-id pub-id-type="pmid">23785335</pub-id></mixed-citation>
</ref>
<ref id="bib77">
<mixed-citation publication-type="journal">Coyle JT. <article-title>NMDA receptor and schizophrenia: a brief history</article-title>. <source/>Schizophr Bull
<year>2012</year>; <volume>38</volume>: <fpage>920</fpage>–926.<pub-id pub-id-type="pmid">22987850</pub-id></mixed-citation>
</ref>
<ref id="bib78">
<mixed-citation publication-type="journal">Nierenberg AA. <article-title>Predictors of response to antidepressants general principles and clinical implications</article-title>. <source/>Psychiatr Clin North Am
<year>2003</year>; <volume>26</volume>: <fpage>345</fpage>–352, viii.<pub-id pub-id-type="pmid">12778837</pub-id></mixed-citation>
</ref>
<ref id="bib79">
<mixed-citation publication-type="journal">Zhang JP, Malhotra AK. <article-title>Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction</article-title>. <source/>Expert Opin Drug Metab Toxicol
<year>2011</year>; <volume>7</volume>: <fpage>9</fpage>–37.<pub-id pub-id-type="pmid">21162693</pub-id></mixed-citation>
</ref>
<ref id="bib80">
<mixed-citation publication-type="journal">Elmer GW, Remmel RP. <article-title>Role of the intestinal microflora in clonazepam metabolism in the rat</article-title>. <source/>Xenobiotica
<year>1984</year>; <volume>14</volume>: <fpage>829</fpage>–840.<pub-id pub-id-type="pmid">6506755</pub-id></mixed-citation>
</ref>
<ref id="bib81">
<mixed-citation publication-type="journal">Taylor K, Elliott S. <article-title>An unusual case of risperidone instability in a fatality presenting an analytical and interpretative challenge</article-title>. <source/>Drug Test Anal
<year>2013</year>; <volume>5</volume>: <fpage>748</fpage>–752.<pub-id pub-id-type="pmid">23868704</pub-id></mixed-citation>
</ref>
<ref id="bib82">
<mixed-citation publication-type="journal">Fiddian-Green RG. <article-title><italic>Helicobacter pylori</italic> eradication and L-dopa absorption in patients with PD and motor fluctuations</article-title>. <source/>Neurology
<year>2007</year>; <volume>68</volume>: <fpage>1085</fpage>.</mixed-citation>
</ref>
<ref id="bib83">
<mixed-citation publication-type="journal">Meinl W, Sczesny S, Brigelius-Flohé R, Blaut M, Glatt H. <article-title>Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat</article-title>. <source/>Drug Metab Dispos
<year>2009</year>; <volume>37</volume>: <fpage>1179</fpage>–1186.<pub-id pub-id-type="pmid">19282396</pub-id></mixed-citation>
</ref>
<ref id="bib84">
<mixed-citation publication-type="journal">Claus SP, Ellero SL, Berger B, Krause L, Bruttin A, Molina J et al. <article-title>Colonization-induced host-gut microbial metabolic interaction</article-title>. <source/>MBio
<year>2011</year>; <volume>2</volume>: <fpage>e00271</fpage>–10.<pub-id pub-id-type="pmid">21363910</pub-id></mixed-citation>
</ref>
<ref id="bib85">
<mixed-citation publication-type="journal">Davey KJ, O'Mahony SM, Schellekens H, O'Sullivan O, Bienenstock J, Cotter PD et al. <article-title>Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters</article-title>. <source/>Psychopharmacology (Berl)
<year>2012</year>; <volume>221</volume>: <fpage>155</fpage>–169.<pub-id pub-id-type="pmid">22234378</pub-id></mixed-citation>
</ref>
<ref id="bib86">
<mixed-citation publication-type="journal">Ley RE, Turnbaugh PJ, Klein S, Gordon JI. <article-title>Microbial ecology: human gut microbes associated with obesity</article-title>. <source/>Nature
<year>2006</year>; <volume>444</volume>: <fpage>1022</fpage>–1023.<pub-id pub-id-type="pmid">17183309</pub-id></mixed-citation>
</ref>
<ref id="bib87">
<mixed-citation publication-type="journal">Davey KJ, Cotter PD, O'Sullivan O, Crispie F, Dinan TG, Cryan JF et al. <article-title>Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat</article-title>. <source/>Transl Psychiatry
<year>2013</year>; <volume>3</volume>: <fpage>e309</fpage>.<pub-id pub-id-type="pmid">24084940</pub-id></mixed-citation>
</ref>
<ref id="bib88">
<mixed-citation publication-type="journal">McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L et al. <article-title>Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III</article-title>. <source/>Schizophr Res
<year>2005</year>; <volume>80</volume>: <fpage>19</fpage>–32.<pub-id pub-id-type="pmid">16137860</pub-id></mixed-citation>
</ref>
<ref id="bib89">
<mixed-citation publication-type="journal">Osby U, Correia N, Brandt L, Ekbom A, Sparén P. <article-title>Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study</article-title>. <source/>BMJ
<year>2000</year>; <volume>321</volume>: <fpage>483</fpage>–484.<pub-id pub-id-type="pmid">10948028</pub-id></mixed-citation>
</ref>
<ref id="bib90">
<mixed-citation publication-type="journal">Emul M, Kalelioglu T. <article-title>Etiology of cardiovascular disease in patients with schizophrenia: current perspectives</article-title>. <source/>Neuropsychiatr Dis Treat
<year>2015</year>; <volume>11</volume>: <fpage>2493</fpage>–2503.<pub-id pub-id-type="pmid">26491327</pub-id></mixed-citation>
</ref>
<ref id="bib91">
<mixed-citation publication-type="journal">Wong EH, Fox JC, Ng MY, Lee CM. <article-title>Toward personalized medicine in the neuropsychiatric field</article-title>. <source/>Int Rev Neurobiol
<year>2011</year>; <volume>101</volume>: <fpage>329</fpage>–349.<pub-id pub-id-type="pmid">22050858</pub-id></mixed-citation>
</ref>
<ref id="bib92">
<mixed-citation publication-type="journal">Alhajji L, Nemeroff CB. <article-title>Personalized medicine and mood disorders</article-title>. <source/>Psychiatr Clin North Am
<year>2015</year>; <volume>38</volume>: <fpage>395</fpage>–403.<pub-id pub-id-type="pmid">26300030</pub-id></mixed-citation>
</ref>
<ref id="bib93">
<mixed-citation publication-type="journal">Rogers GB, Wesselingh S. <article-title>Precision respiratory medicine and the microbiome</article-title>. <source/>Lancet Respir Med
<year>2016</year>; <volume>4</volume>: <fpage>73</fpage>–82.<pub-id pub-id-type="pmid">26700443</pub-id></mixed-citation>
</ref>
<ref id="bib94">
<mixed-citation publication-type="journal">O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. <article-title>Serotonin, tryptophan metabolism and the brain-gut-microbiome axis</article-title>. <source/>Behav Brain Res
<year>2015</year>; <volume>277</volume>: <fpage>32</fpage>–48.<pub-id pub-id-type="pmid">25078296</pub-id></mixed-citation>
</ref>
<ref id="bib95">
<mixed-citation publication-type="journal">Ben-Ari Y. <article-title>Neuropaediatric and neuroarchaeology: understanding development to correct brain disorders</article-title>. <source/>Acta Paediatr
<year>2013</year>; <volume>102</volume>: <fpage>331</fpage>–334.<pub-id pub-id-type="pmid">23906430</pub-id></mixed-citation>
</ref>
<ref id="bib96">
<mixed-citation publication-type="journal">Rapoport JL, Giedd JN, Gogtay N. <article-title>Neurodevelopmental model of schizophrenia: update 2012</article-title>. <source/>Mol Psychiatry
<year>2012</year>; <volume>17</volume>: <fpage>1228</fpage>–1238.<pub-id pub-id-type="pmid">22488257</pub-id></mixed-citation>
</ref>
<ref id="bib97">
<mixed-citation publication-type="journal">Guerri C. <article-title>Neuroanatomical and neurophysiological mechanisms involved in central nervous system dysfunctions induced by prenatal alcohol exposure</article-title>. <source/>Alcohol Clin Exp Res
<year>1998</year>; <volume>22</volume>: <fpage>304</fpage>–312.<pub-id pub-id-type="pmid">9581633</pub-id></mixed-citation>
</ref>
<ref id="bib98">
<mixed-citation publication-type="journal">Jašarević E, Rodgers AB, Bale TL. <article-title>A novel role for maternal stress and microbial transmission in early life programming and neurodevelopment</article-title>. <source/>Neurobiol Stress
<year>2015</year>; <volume>1</volume>: <fpage>81</fpage>–88.<pub-id pub-id-type="pmid">25530984</pub-id></mixed-citation>
</ref>
<ref id="bib99">
<mixed-citation publication-type="journal">Brown AS, Susser ES. <article-title>Prenatal nutritional deficiency and risk of adult schizophrenia</article-title>. <source/>Schizophr Bull
<year>2008</year>; <volume>34</volume>: <fpage>1054</fpage>–1063.<pub-id pub-id-type="pmid">18682377</pub-id></mixed-citation>
</ref>
<ref id="bib100">
<mixed-citation publication-type="journal">Van Lieshout RJ, Taylor VH, Boyle MH. <article-title>Pre-pregnancy and pregnancy obesity and neurodevelopmental outcomes in offspring: a systematic review</article-title>. <source/>Obes Rev
<year>2011</year>; <volume>12</volume>: <fpage>e548</fpage>–e559.<pub-id pub-id-type="pmid">21414129</pub-id></mixed-citation>
</ref>
<ref id="bib101">
<mixed-citation publication-type="journal">Wischhof L, Irrsack E, Osorio C, Koch M. <article-title>Prenatal LPS-exposure—a neurodevelopmental rat model of schizophrenia—differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspring</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry
<year>2015</year>; <volume>57</volume>: <fpage>17</fpage>–30.<pub-id pub-id-type="pmid">25455585</pub-id></mixed-citation>
</ref>
<ref id="bib102">
<mixed-citation publication-type="journal">Meyer U, Feldon J, Yee BK. <article-title>A review of the fetal brain cytokine imbalance hypothesis of schizophrenia</article-title>. <source/>Schizophr Bull
<year>2009</year>; <volume>35</volume>: <fpage>959</fpage>–972.<pub-id pub-id-type="pmid">18408229</pub-id></mixed-citation>
</ref>
<ref id="bib103">
<mixed-citation publication-type="journal">Finegold SM. <article-title>State of the art; microbiology in health and disease. Intestinal bacterial flora in autism</article-title>. <source/>Anaerobe
<year>2011</year>; <volume>17</volume>: <fpage>367</fpage>–368.<pub-id pub-id-type="pmid">21524713</pub-id></mixed-citation>
</ref>
<ref id="bib104">
<mixed-citation publication-type="journal">Glynn LM, Wadhwa PD, Dunkel-Schetter C, Chicz-Demet A, Sandman CA. <article-title>When stress happens matters: effects of earthquake timing on stress responsivity in pregnancy</article-title>. <source/>Am J Obstet Gynecol
<year>2001</year>; <volume>184</volume>: <fpage>637</fpage>–642.<pub-id pub-id-type="pmid">11262465</pub-id></mixed-citation>
</ref>
<ref id="bib105">
<mixed-citation publication-type="journal">Brown PL, Shepard PD, Elmer GI, Stockman S, McFarland R, Mayo CL et al. <article-title>Altered spatial learning, cortical plasticity and hippocampal anatomy in a neurodevelopmental model of schizophrenia-related endophenotypes</article-title>. <source/>Eur J Neurosci
<year>2012</year>; <volume>36</volume>: <fpage>2773</fpage>–2781.<pub-id pub-id-type="pmid">22762562</pub-id></mixed-citation>
</ref>
<ref id="bib106">
<mixed-citation publication-type="journal">Howerton CL, Bale TL. <article-title>Prenatal programing: at the intersection of maternal stress and immune activation</article-title>. <source/>Horm Behav
<year>2012</year>; <volume>62</volume>: <fpage>237</fpage>–242.<pub-id pub-id-type="pmid">22465455</pub-id></mixed-citation>
</ref>
<ref id="bib107">
<mixed-citation publication-type="journal">Marques AH, O'Connor TG, Roth C, Susser E, Bjørke-Monsen AL. <article-title>The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders</article-title>. <source/>Front Neurosci
<year>2013</year>; <volume>7</volume>: <fpage>120</fpage>.<pub-id pub-id-type="pmid">23914151</pub-id></mixed-citation>
</ref>
<ref id="bib108">
<mixed-citation publication-type="journal">Goehler LE, Park SM, Opitz N, Lyte M, Gaykema RP. <article-title><italic>Campylobacter jejuni</italic> infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior</article-title>. <source/>Brain Behav Immun
<year>2008</year>; <volume>22</volume>: <fpage>354</fpage>–366.<pub-id pub-id-type="pmid">17920243</pub-id></mixed-citation>
</ref>
<ref id="bib109">
<mixed-citation publication-type="journal">Bilbo SD, Levkoff LH, Mahoney JH, Watkins LR, Rudy JW, Maier SF. <article-title>Neonatal infection induces memory impairments following an immune challenge in adulthood</article-title>. <source/>Behav Neurosci
<year>2005</year>; <volume>119</volume>: <fpage>293</fpage>–301.<pub-id pub-id-type="pmid">15727533</pub-id></mixed-citation>
</ref>
<ref id="bib110">
<mixed-citation publication-type="journal">Sullivan EL, Riper KM, Lockard R, Valleau JC. <article-title>Maternal high-fat diet programming of the neuroendocrine system and behavior</article-title>. <source/>Horm Behav
<year>2015</year>; <volume>76</volume>: <fpage>153</fpage>–161.<pub-id pub-id-type="pmid">25913366</pub-id></mixed-citation>
</ref>
<ref id="bib111">
<mixed-citation publication-type="journal">Sasaki A, de Vega W, Sivanathan S, St-Cyr S, McGowan PO. <article-title>Maternal high-fat diet alters anxiety behavior and glucocorticoid signaling in adolescent offspring</article-title>. <source/>Neuroscience
<year>2014</year>; <volume>272</volume>: <fpage>92</fpage>–101.<pub-id pub-id-type="pmid">24791714</pub-id></mixed-citation>
</ref>
<ref id="bib112">
<mixed-citation publication-type="journal">Strandberg L, Verdrengh M, Enge M, Andersson N, Amu S, Onnheim K et al. <article-title>Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis</article-title>. <source/>PLoS One
<year>2009</year>; <volume>4</volume>: <fpage>e7605</fpage>.<pub-id pub-id-type="pmid">19865485</pub-id></mixed-citation>
</ref>
<ref id="bib113">
<mixed-citation publication-type="journal">Verwaerde C, Delanoye A, Macia L, Tailleux A, Wolowczuk I. <article-title>Influence of high-fat feeding on both naive and antigen-experienced T-cell immune response in DO10.11 mice</article-title>. <source/>Scand J Immunol
<year>2006</year>; <volume>64</volume>: <fpage>457</fpage>–466.<pub-id pub-id-type="pmid">17032237</pub-id></mixed-citation>
</ref>
<ref id="bib114">
<mixed-citation publication-type="journal">Choi MS, Kim YJ, Kwon EY, Ryoo JY, Kim SR, Jung UJ. <article-title>High-fat diet decreases energy expenditure and expression of genes controlling lipid metabolism, mitochondrial function and skeletal system development in the adipose tissue, along with increased expression of extracellular matrix remodelling- and inflammation-related genes</article-title>. <source/>Br J Nutr
<year>2015</year>; <volume>113</volume>: <fpage>867</fpage>–877.<pub-id pub-id-type="pmid">25744306</pub-id></mixed-citation>
</ref>
<ref id="bib115">
<mixed-citation publication-type="journal">Selevan SG, Kimmel CA, Mendola P. <article-title>Identifying critical windows of exposure for children's health</article-title>. <source/>Environ Health Perspect
<year>2000</year>; <volume>108</volume>: <fpage>451</fpage>–455.<pub-id pub-id-type="pmid">10852844</pub-id></mixed-citation>
</ref>
<ref id="bib116">
<mixed-citation publication-type="journal">Khandaker GM, Zimbron J, Lewis G, Jones PB. <article-title>Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies</article-title>. <source/>Psychol Med
<year>2013</year>; <volume>43</volume>: <fpage>239</fpage>–257.<pub-id pub-id-type="pmid">22717193</pub-id></mixed-citation>
</ref>
<ref id="bib117">
<mixed-citation publication-type="journal">Hsu P, Nanan R. <article-title>Foetal immune programming: hormones, cytokines, microbes and regulatory T cells</article-title>. <source/>J Reprod Immunol
<year>2014</year>; <volume>104-105</volume>: <fpage>2</fpage>–7.<pub-id pub-id-type="pmid">24702950</pub-id></mixed-citation>
</ref>
<ref id="bib118">
<mixed-citation publication-type="journal">Kim DR, Bale TL, Epperson CN. <article-title>Prenatal programming of mental illness: current understanding of relationship and mechanisms</article-title>. <source/>Curr Psychiatry Rep
<year>2015</year>; <volume>17</volume>: <fpage>5</fpage>.<pub-id pub-id-type="pmid">25617041</pub-id></mixed-citation>
</ref>
<ref id="bib119">
<mixed-citation publication-type="journal">Glover V. <article-title>Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms</article-title>. <source/>Adv Neurobiol
<year>2015</year>; <volume>10</volume>: <fpage>269</fpage>–283.<pub-id pub-id-type="pmid">25287545</pub-id></mixed-citation>
</ref>
<ref id="bib120">
<mixed-citation publication-type="journal">Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H et al. <article-title>Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota</article-title>. <source/>Nature
<year>2013</year>; <volume>500</volume>: <fpage>232</fpage>–236.<pub-id pub-id-type="pmid">23842501</pub-id></mixed-citation>
</ref>
<ref id="bib121">
<mixed-citation publication-type="journal">Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D et al. <article-title>Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells</article-title>. <source/>Nature
<year>2013</year>; <volume>504</volume>: <fpage>446</fpage>–450.<pub-id pub-id-type="pmid">24226770</pub-id></mixed-citation>
</ref>
<ref id="bib122">
<mixed-citation publication-type="journal">Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M et al. <article-title>The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis</article-title>. <source/>Science
<year>2013</year>; <volume>341</volume>: <fpage>569</fpage>–573.<pub-id pub-id-type="pmid">23828891</pub-id></mixed-citation>
</ref>
<ref id="bib123">
<mixed-citation publication-type="journal">Park BO, Kim SH, Kong GY, Kim DH, Kwon MS, Lee SU et al. <article-title>Selective novel inverse agonists for human GPR43 augment GLP-1 secretion</article-title>. <source/>Eur J Pharmacol
<year>2015</year>; <volume>771</volume>: <fpage>1</fpage>–9.<pub-id pub-id-type="pmid">26683635</pub-id></mixed-citation>
</ref>
<ref id="bib124">
<mixed-citation publication-type="journal">Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, Bunger MK et al. <article-title>The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon</article-title>. <source/>Cell Metab
<year>2011</year>; <volume>13</volume>: <fpage>517</fpage>–526.<pub-id pub-id-type="pmid">21531334</pub-id></mixed-citation>
</ref>
<ref id="bib125">
<mixed-citation publication-type="journal">Schaap LA, Koster A, Visser M. <article-title>Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons</article-title>. <source/>Epidemiol Rev
<year>2013</year>; <volume>35</volume>: <fpage>51</fpage>–65.<pub-id pub-id-type="pmid">23221972</pub-id></mixed-citation>
</ref>
<ref id="bib126">
<mixed-citation publication-type="journal">Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S et al. <article-title>Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation</article-title>. <source/>Nature
<year>2003</year>; <volume>421</volume>: <fpage>384</fpage>–388.<pub-id pub-id-type="pmid">12508119</pub-id></mixed-citation>
</ref>
<ref id="bib127">
<mixed-citation publication-type="journal">de Lartigue G, de La Serre CB, Raybould HE. <article-title>Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin</article-title>. <source/>Physiol Behav
<year>2011</year>; <volume>105</volume>: <fpage>100</fpage>–105.<pub-id pub-id-type="pmid">21376066</pub-id></mixed-citation>
</ref>
<ref id="bib128">
<mixed-citation publication-type="journal">Bailey MT, Dowd SE, Galley JD, Hufnagle AR, Allen RG, Lyte M. <article-title>Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation</article-title>. <source/>Brain Behav Immun
<year>2011</year>; <volume>25</volume>: <fpage>397</fpage>–407.<pub-id pub-id-type="pmid">21040780</pub-id></mixed-citation>
</ref>
<ref id="bib129">
<mixed-citation publication-type="journal">Glover V, O'Connor TG, O'Donnell K. <article-title>Prenatal stress and the programming of the HPA axis</article-title>. <source/>Neurosci Biobehav Rev
<year>2010</year>; <volume>35</volume>: <fpage>17</fpage>–22.<pub-id pub-id-type="pmid">19914282</pub-id></mixed-citation>
</ref>
<ref id="bib130">
<mixed-citation publication-type="journal">Weinstock M. <article-title>The long-term behavioural consequences of prenatal stress</article-title>. <source/>Neurosci Biobehav Rev
<year>2008</year>; <volume>32</volume>: <fpage>1073</fpage>–1086.<pub-id pub-id-type="pmid">18423592</pub-id></mixed-citation>
</ref>
<ref id="bib131">
<mixed-citation publication-type="journal">McCann SM, Antunes-Rodrigues J, Franci CR, Anselmo-Franci JA, Karanth S, Rettori V. <article-title>Role of the hypothalamic pituitary adrenal axis in the control of the response to stress and infection</article-title>. <source/>Braz J Med Biol Res
<year>2000</year>; <volume>33</volume>: <fpage>1121</fpage>–1131.<pub-id pub-id-type="pmid">11004712</pub-id></mixed-citation>
</ref>
<ref id="bib132">
<mixed-citation publication-type="journal">Boersma GJ, Moghadam AA, Cordner ZA, Tamashiro KL. <article-title>Prenatal stress and stress coping style interact to predict metabolic risk in male rats</article-title>. <source/>Endocrinology
<year>2014</year>; <volume>155</volume>: <fpage>1302</fpage>–1312.<pub-id pub-id-type="pmid">24467745</pub-id></mixed-citation>
</ref>
<ref id="bib133">
<mixed-citation publication-type="journal">Ronald A, Pennell CE, Whitehouse AJ. <article-title>Prenatal maternal stress associated with ADHD and autistic traits in early childhood</article-title>. <source/>Front Psychol
<year>2011</year>; <volume>1</volume>: <fpage>223</fpage>.<pub-id pub-id-type="pmid">21833278</pub-id></mixed-citation>
</ref>
<ref id="bib134">
<mixed-citation publication-type="journal">Class QA, Abel KM, Khashan AS, Rickert ME, Dalman C, Larsson H et al. <article-title>Offspring psychopathology following preconception, prenatal and postnatal maternal bereavement stress</article-title>. <source/>Psychol Med
<year>2014</year>; <volume>44</volume>: <fpage>71</fpage>–84.<pub-id pub-id-type="pmid">23591021</pub-id></mixed-citation>
</ref>
<ref id="bib135">
<mixed-citation publication-type="journal">O'Connor TG, Heron J, Golding J, Beveridge M, Glover V. <article-title>Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children</article-title>. <source/>Br J Psychiatry
<year>2002</year>; <volume>180</volume>: <fpage>502</fpage>–508.<pub-id pub-id-type="pmid">12042228</pub-id></mixed-citation>
</ref>
<ref id="bib136">
<mixed-citation publication-type="journal">Huizink AC, Robles de Medina PG, Mulder EJ, Visser GH, Buitelaar JK. <article-title>Stress during pregnancy is associated with developmental outcome in infancy</article-title>. <source/>J Child Psychol Psychiatry
<year>2003</year>; <volume>44</volume>: <fpage>810</fpage>–818.<pub-id pub-id-type="pmid">12959490</pub-id></mixed-citation>
</ref>
<ref id="bib137">
<mixed-citation publication-type="journal">Dumont TM, Rughani AI, Penar PL, Horgan MA, Tranmer BI, Jewell RP. <article-title>Increased rate of complications on a neurological surgery service after implementation of the Accreditation Council for Graduate Medical Education work-hour restriction</article-title>. <source/>J Neurosurg
<year>2012</year>; <volume>116</volume>: <fpage>483</fpage>–486.<pub-id pub-id-type="pmid">22136642</pub-id></mixed-citation>
</ref>
<ref id="bib138">
<mixed-citation publication-type="journal">Söderholm JD, Yates DA, Gareau MG, Yang PC, MacQueen G, Perdue MH. <article-title>Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol
<year>2002</year>; <volume>283</volume>: <fpage>G1257</fpage>–G1263.<pub-id pub-id-type="pmid">12388189</pub-id></mixed-citation>
</ref>
<ref id="bib139">
<mixed-citation publication-type="journal">Otten W, Kanitz E, Tuchscherer M, Gräbner M, Nürnberg G, Bellmann O et al. <article-title>Effects of low and high protein:carbohydrate ratios in the diet of pregnant gilts on maternal cortisol concentrations and the adrenocortical and sympathoadrenal reactivity in their offspring. 2013</article-title>. <source/>J Anim Sci
<year>2013</year>; <volume>91</volume>: <fpage>2680</fpage>–2692.<pub-id pub-id-type="pmid">23482575</pub-id></mixed-citation>
</ref>
<ref id="bib140">
<mixed-citation publication-type="journal">Keating DJ, Rychkov GY, Adams MB, Holgert H, McMillen IC, Roberts ML. <article-title>Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca(2+) and K(+) channels</article-title>. <source/>J Physiol
<year>2004</year>; <volume>555</volume>: <fpage>489</fpage>–502.<pub-id pub-id-type="pmid">14724210</pub-id></mixed-citation>
</ref>
<ref id="bib141">
<mixed-citation publication-type="journal">Keating DJ, Rychkov GY, Roberts ML. <article-title>Oxygen sensitivity in the sheep adrenal medulla: role of SK channels</article-title>. <source/>Am J Physiol Cell Physiol
<year>2001</year>; <volume>281</volume>: <fpage>C1434</fpage>–C1441.<pub-id pub-id-type="pmid">11600405</pub-id></mixed-citation>
</ref>
<ref id="bib142">
<mixed-citation publication-type="other">Slotkin TA, Orband-Miller L, Queen KL Do catecholamines contribute to the effects of neonatal hypoxia on development of brain and heart? Influence of concurrent alpha-adrenergic blockade on ornithine decarboxylase activity. Int J Dev Neurosci 1987; 5: 135–143..</mixed-citation>
</ref>
<ref id="bib143">
<mixed-citation publication-type="book">Glover V. <article-title>Prenatal stress and child outcomes</article-title>. In: Antonelli MC (ed). <source/>Advances in Neurobiology Perinatal Programming of Neurodevelopment. Springer: New York, <year>2015</year>, pp <fpage>269</fpage>–283.</mixed-citation>
</ref>
<ref id="bib144">
<mixed-citation publication-type="journal">Salaria S, Chana G, Caldara F, Feltrin E, Altieri M, Faggioni F et al. <article-title>Microarray analysis of cultured human brain aggregates following cortisol exposure: implications for cellular functions relevant to mood disorders</article-title>. <source/>Neurobiol Dis
<year>2006</year>; <volume>23</volume>: <fpage>630</fpage>–636.<pub-id pub-id-type="pmid">16844382</pub-id></mixed-citation>
</ref>
<ref id="bib145">
<mixed-citation publication-type="journal">Crudo A, Suderman M, Moisiadis VG, Petropoulos S, Kostaki A, Hallett M et al. <article-title>Glucocorticoid programming of the fetal male hippocampal epigenome</article-title>. <source/>Endocrinology
<year>2013</year>; <volume>154</volume>: <fpage>1168</fpage>–1180.<pub-id pub-id-type="pmid">23389956</pub-id></mixed-citation>
</ref>
<ref id="bib146">
<mixed-citation publication-type="journal">Golubeva AV, Crampton S, Desbonnet L, Edge D, O'Sullivan O, Lomasney KW et al. <article-title>Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood</article-title>. <source/>Psychoneuroendocrinology
<year>2015</year>; <volume>60</volume>: <fpage>58</fpage>–74.<pub-id pub-id-type="pmid">26135201</pub-id></mixed-citation>
</ref>
<ref id="bib147">
<mixed-citation publication-type="journal">Jansson T, Powell TL. <article-title>Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches</article-title>. <source/>Clin Sci (Lond)
<year>2007</year>; <volume>113</volume>: <fpage>1</fpage>–13.<pub-id pub-id-type="pmid">17536998</pub-id></mixed-citation>
</ref>
<ref id="bib148">
<mixed-citation publication-type="journal">Mairesse J, Lesage J, Breton C, Bréant B, Hahn T, Darnaudéry M et al. <article-title>Maternal stress alters endocrine function of the feto-placental unit in rats</article-title>. <source/>Am J Physiol Endocrinol Metab
<year>2007</year>; <volume>292</volume>: <fpage>E1526</fpage>–E1533.<pub-id pub-id-type="pmid">17264224</pub-id></mixed-citation>
</ref>
<ref id="bib149">
<mixed-citation publication-type="journal">Welberg LA, Thrivikraman KV, Plotsky PM. <article-title>Chronic maternal stress inhibits the capacity to up-regulate placental 11beta-hydroxysteroid dehydrogenase type 2 activity</article-title>. <source/>J Endocrinol
<year>2005</year>; <volume>186</volume>: <fpage>R7</fpage>–R12.<pub-id pub-id-type="pmid">16135661</pub-id></mixed-citation>
</ref>
<ref id="bib150">
<mixed-citation publication-type="journal">Glover V, Bergman K, Sarkar P, O'Connor TG. <article-title>Association between maternal and amniotic fluid cortisol is moderated by maternal anxiety</article-title>. <source/>Psychoneuroendocrinology
<year>2009</year>; <volume>34</volume>: <fpage>430</fpage>–435.<pub-id pub-id-type="pmid">19019559</pub-id></mixed-citation>
</ref>
<ref id="bib151">
<mixed-citation publication-type="journal">Gaspar P, Cases O, Maroteaux L. <article-title>The developmental role of serotonin: news from mouse molecular genetics</article-title>. <source/>Nat Rev Neurosci
<year>2003</year>; <volume>4</volume>: <fpage>1002</fpage>–1012.<pub-id pub-id-type="pmid">14618156</pub-id></mixed-citation>
</ref>
<ref id="bib152">
<mixed-citation publication-type="journal">Mazer C, Muneyyirci J, Taheny K, Raio N, Borella A, Whitaker-Azmitia P. <article-title>Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits</article-title>. <source/>Brain Res
<year>1997</year>; <volume>760</volume>: <fpage>68</fpage>–73.<pub-id pub-id-type="pmid">9237519</pub-id></mixed-citation>
</ref>
<ref id="bib153">
<mixed-citation publication-type="journal">Côté F, Fligny C, Bayard E, Launay JM, Gershon MD, Mallet J et al. <article-title>Maternal serotonin is crucial for murine embryonic development</article-title>. <source/>Proc Natl Acad Sci USA
<year>2007</year>; <volume>104</volume>: <fpage>329</fpage>–334.<pub-id pub-id-type="pmid">17182745</pub-id></mixed-citation>
</ref>
<ref id="bib154">
<mixed-citation publication-type="journal">Engelhardt B. <article-title>Development of the blood-brain barrier</article-title>. <source/>Cell Tissue Res
<year>2003</year>; <volume>314</volume>: <fpage>119</fpage>–129.<pub-id pub-id-type="pmid">12955493</pub-id></mixed-citation>
</ref>
<ref id="bib155">
<mixed-citation publication-type="journal">Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M et al. <article-title>The gut microbiota influences blood-brain barrier permeability in mice</article-title>. <source/>Sci Transl Med
<year>2014</year>; <volume>6</volume><source/>263ra158.
</mixed-citation>
</ref>
<ref id="bib156">
<mixed-citation publication-type="journal">Anderson GM. <article-title>Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism</article-title>. <source/>J Am Acad Child Adolesc Psychiatry
<year>2002</year>; <volume>41</volume>: <fpage>1513</fpage>–1516.<pub-id pub-id-type="pmid">12447040</pub-id></mixed-citation>
</ref>
<ref id="bib157">
<mixed-citation publication-type="journal">Borre YE, O'Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. <article-title>Microbiota and neurodevelopmental windows: implications for brain disorders</article-title>. <source/>Trends Mol Med
<year>2014</year>; <volume>20</volume>: <fpage>509</fpage>–518.<pub-id pub-id-type="pmid">24956966</pub-id></mixed-citation>
</ref>
<ref id="bib158">
<mixed-citation publication-type="journal">Herschkowitz N, Kagan J, Zilles K. <article-title>Neurobiological bases of behavioral development in the first year</article-title>. <source/>Neuropediatrics
<year>1997</year>; <volume>28</volume>: <fpage>296</fpage>–306.<pub-id pub-id-type="pmid">9453026</pub-id></mixed-citation>
</ref>
<ref id="bib159">
<mixed-citation publication-type="journal">Petanjek Z, Judaš M, Šimic G, Rasin MR, Uylings HB, Rakic P et al. <article-title>Extraordinary neoteny of synaptic spines in the human prefrontal cortex</article-title>. <source/>Proc Natl Acad Sci USA
<year>2011</year>; <volume>108</volume>: <fpage>13281</fpage>–13286.<pub-id pub-id-type="pmid">21788513</pub-id></mixed-citation>
</ref>
<ref id="bib160">
<mixed-citation publication-type="journal">Karmarkar D, Rock KL. <article-title>Microbiota signalling through MyD88 is necessary for a systemic neutrophilic inflammatory response</article-title>. <source/>Immunology
<year>2013</year>; <volume>140</volume>: <fpage>483</fpage>–492.<pub-id pub-id-type="pmid">23909393</pub-id></mixed-citation>
</ref>
<ref id="bib161">
<mixed-citation publication-type="journal">Abt MC, Osborne LC, Monticelli LA, Doering TA, Alenghat T, Sonnenberg GF et al. <article-title>Commensal bacteria calibrate the activation threshold of innate antiviral immunity</article-title>. <source/>Immunity
<year>2012</year>; <volume>37</volume>: <fpage>158</fpage>–170.<pub-id pub-id-type="pmid">22705104</pub-id></mixed-citation>
</ref>
<ref id="bib162">
<mixed-citation publication-type="journal">Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P et al. <article-title>Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation</article-title>. <source/>Nature
<year>2013</year>; <volume>504</volume>: <fpage>451</fpage>–455.<pub-id pub-id-type="pmid">24226773</pub-id></mixed-citation>
</ref>
<ref id="bib163">
<mixed-citation publication-type="journal">Artis D. <article-title>Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut</article-title>. <source/>Nat Rev Immunol
<year>2008</year>; <volume>8</volume>: <fpage>411</fpage>–420.<pub-id pub-id-type="pmid">18469830</pub-id></mixed-citation>
</ref>
<ref id="bib164">
<mixed-citation publication-type="journal">Kaplan JL, Shi HN, Walker WA. <article-title>The role of microbes in developmental immunologic programming</article-title>. <source/>Pediatr Res
<year>2011</year>; <volume>69</volume>: <fpage>465</fpage>–472.<pub-id pub-id-type="pmid">21364495</pub-id></mixed-citation>
</ref>
<ref id="bib165">
<mixed-citation publication-type="journal">Clarke G, O'Mahony SM, Dinan TG, Cryan JF. <article-title>Priming for health: gut microbiota acquired in early life regulates physiology, brain and behaviour</article-title>. <source/>Acta Paediatr
<year>2014</year>; <volume>103</volume>: <fpage>812</fpage>–819.<pub-id pub-id-type="pmid">24798884</pub-id></mixed-citation>
</ref>
<ref id="bib166">
<mixed-citation publication-type="journal">Goulet O. <article-title>Potential role of the intestinal microbiota in programming health and disease</article-title>. <source/>Nutr Rev
<year>2015</year>; <volume>73</volume>: <fpage>32</fpage>–40.<pub-id pub-id-type="pmid">26175488</pub-id></mixed-citation>
</ref>
<ref id="bib167">
<mixed-citation publication-type="journal">Arrieta MC, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B. <article-title>The intestinal microbiome in early life: health and disease</article-title>. <source/>Front Immunol
<year>2014</year>; <volume>5</volume>: <fpage>427</fpage>.<pub-id pub-id-type="pmid">25250028</pub-id></mixed-citation>
</ref>
<ref id="bib168">
<mixed-citation publication-type="journal">Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF. <article-title>Microbiota is essential for social development in the mouse</article-title>. <source/>Mol Psychiatry
<year>2014</year>; <volume>19</volume>: <fpage>146</fpage>–148.<pub-id pub-id-type="pmid">23689536</pub-id></mixed-citation>
</ref>
<ref id="bib169">
<mixed-citation publication-type="journal">Amaral FA, Sachs D, Costa VV, Fagundes CT, Cisalpino D, Cunha TM et al. <article-title>Commensal microbiota is fundamental for the development of inflammatory pain</article-title>. <source/>Proc Natl Acad Sci USA
<year>2008</year>; <volume>105</volume>: <fpage>2193</fpage>–2197.<pub-id pub-id-type="pmid">18268332</pub-id></mixed-citation>
</ref>
<ref id="bib170">
<mixed-citation publication-type="journal">Neufeld KA, Kang N, Bienenstock J, Foster JA. <article-title>Effects of intestinal microbiota on anxiety-like behavior</article-title>. <source/>Commun Integr Biol
<year>2011</year>; <volume>4</volume>: <fpage>492</fpage>–494.<pub-id pub-id-type="pmid">21966581</pub-id></mixed-citation>
</ref>
<ref id="bib171">
<mixed-citation publication-type="journal">Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N et al. <article-title>Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns</article-title>. <source/>Proc Natl Acad Sci USA
<year>2010</year>; <volume>107</volume>: <fpage>11971</fpage>–11975.<pub-id pub-id-type="pmid">20566857</pub-id></mixed-citation>
</ref>
<ref id="bib172">
<mixed-citation publication-type="journal">Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, Retetangos C. <article-title>Mode of delivery affects the bacterial community in the newborn gut</article-title>. <source/>Early Hum Dev
<year>2010</year>; <volume>86</volume>: <fpage>13</fpage>–15.</mixed-citation>
</ref>
<ref id="bib173">
<mixed-citation publication-type="journal">Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF. <article-title>Perinatal factors and the development of autism: a population study</article-title>. <source/>Arch Gen Psychiatry
<year>2004</year>; <volume>61</volume>: <fpage>618</fpage>–627.<pub-id pub-id-type="pmid">15184241</pub-id></mixed-citation>
</ref>
<ref id="bib174">
<mixed-citation publication-type="journal">Li HT, Ye R, Achenbach TM, Ren A, Pei L, Zheng X et al. <article-title>Caesarean delivery on maternal request and childhood psychopathology: a retrospective cohort study in China</article-title>. <source/>BJOG
<year>2011</year>; <volume>118</volume>: <fpage>42</fpage>–48.<pub-id pub-id-type="pmid">21050366</pub-id></mixed-citation>
</ref>
<ref id="bib175">
<mixed-citation publication-type="journal">Al Khalaf SY, O'Neill SM, O'Keeffe LM, Henriksen TB, Kenny LC, Cryan JF et al. <article-title>The impact of obstetric mode of delivery on childhood behavior</article-title>. <source/>Soc Psychiatry Psychiatr Epidemiol
<year>2015</year>; <volume>50</volume>: <fpage>1557</fpage>–1567.<pub-id pub-id-type="pmid">25868660</pub-id></mixed-citation>
</ref>
<ref id="bib176">
<mixed-citation publication-type="journal">Borre YE, Moloney RD, Clarke G, Dinan TG, Cryan JF. <article-title>The impact of microbiota on brain and behavior: mechanisms &amp; therapeutic potential</article-title>. <source/>Adv Exp Med Biol
<year>2014</year>; <volume>817</volume>: <fpage>373</fpage>–403.<pub-id pub-id-type="pmid">24997043</pub-id></mixed-citation>
</ref>
<ref id="bib177">
<mixed-citation publication-type="journal">Thum C, Cookson AL, Otter DE, McNabb WC, Hodgkinson AJ, Dyer J et al. <article-title>Can nutritional modulation of maternal intestinal microbiota influence the development of the infant gastrointestinal tract</article-title>? <source/>J Nutr
<year>2012</year>; <volume>142</volume>: <fpage>1921</fpage>–1928.<pub-id pub-id-type="pmid">22990463</pub-id></mixed-citation>
</ref>
<ref id="bib178">
<mixed-citation publication-type="journal">Tannock GW, Savage DC. <article-title>Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract</article-title>. <source/>Infect Immun
<year>1974</year>; <volume>9</volume>: <fpage>591</fpage>–598.<pub-id pub-id-type="pmid">4593471</pub-id></mixed-citation>
</ref>
<ref id="bib179">
<mixed-citation publication-type="journal">Jašarević E, Howerton CL, Howard CD, Bale TL. <article-title>Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain</article-title>. <source/>Endocrinology
<year>2015</year>; <volume>156</volume>: <fpage>3265</fpage>–3276.<pub-id pub-id-type="pmid">26079804</pub-id></mixed-citation>
</ref>
<ref id="bib180">
<mixed-citation publication-type="journal">Zijlmans MA, Korpela K, Riksen-Walraven JM, de Vos WM, de Weerth C. <article-title>Maternal prenatal stress is associated with the infant intestinal microbiota</article-title>. <source/>Psychoneuroendocrinology
<year>2015</year>; <volume>53</volume>: <fpage>233</fpage>–245.<pub-id pub-id-type="pmid">25638481</pub-id></mixed-citation>
</ref>
<ref id="bib181">
<mixed-citation publication-type="journal">Fåk F, Ahrné S, Molin G, Jeppsson B, Weström B. <article-title>Microbial manipulation of the rat dam changes bacterial colonization and alters properties of the gut in her offspring</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol
<year>2008</year>; <volume>294</volume>: <fpage>G148</fpage>–G154.<pub-id pub-id-type="pmid">17962363</pub-id></mixed-citation>
</ref>
<ref id="bib182">
<mixed-citation publication-type="journal">Tormo-Badia N, Håkansson Å, Vasudevan K, Molin G, Ahrné S, Cilio CM. <article-title>Antibiotic treatment of pregnant non-obese diabetic mice leads to altered gut microbiota and intestinal immunological changes in the offspring</article-title>. <source/>Scand J Immunol
<year>2014</year>; <volume>80</volume>: <fpage>250</fpage>–260.<pub-id pub-id-type="pmid">24965690</pub-id></mixed-citation>
</ref>
<ref id="bib183">
<mixed-citation publication-type="other">Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ et al. <article-title>Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study</article-title>. <source/>BJOG; doi: 10.1111/1471-0528.13601; e-pub ahead of print.</mixed-citation>
</ref>
<ref id="bib184">
<mixed-citation publication-type="journal">Tanaka S, Kobayashi T, Songjinda P, Tateyama A, Tsubouchi M, Kiyohara C et al. <article-title>Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota</article-title>. <source/>FEMS Immunol Med Microbiol
<year>2009</year>; <volume>56</volume>: <fpage>80</fpage>–87.<pub-id pub-id-type="pmid">19385995</pub-id></mixed-citation>
</ref>
<ref id="bib185">
<mixed-citation publication-type="journal">Deshmukh HS, Liu Y, Menkiti OR, Mei J, Dai N, O'Leary CE et al. <article-title>The microbiota regulates neutrophil homeostasis and host resistance to <italic>Escherichia coli</italic> K1 sepsis in neonatal mice</article-title>. <source/>Nat Med
<year>2014</year>; <volume>20</volume>: <fpage>524</fpage>–530.<pub-id pub-id-type="pmid">24747744</pub-id></mixed-citation>
</ref>
<ref id="bib186">
<mixed-citation publication-type="journal">O'Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P et al. <article-title>Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats</article-title>. <source/>Neuroscience
<year>2014</year>; <volume>277</volume>: <fpage>885</fpage>–901.<pub-id pub-id-type="pmid">25088912</pub-id></mixed-citation>
</ref>
<ref id="bib187">
<mixed-citation publication-type="journal">Desbonnet L, Clarke G, Traplin A, O'Sullivan O, Crispie F, Moloney RD et al. <article-title>Gut microbiota depletion from early adolescence in mice: implications for brain and behaviour</article-title>. <source/>Brain Behav Immun
<year>2015</year>; <volume>48</volume>: <fpage>165</fpage>–173.<pub-id pub-id-type="pmid">25866195</pub-id></mixed-citation>
</ref>
<ref id="bib188">
<mixed-citation publication-type="journal">Giriko CÁ, Andreoli CA, Mennitti LV, Hosoume LF, Souto Tdos S, Silva AV et al. <article-title>Delayed physical and neurobehavioral development and increased aggressive and depression-like behaviors in the rat offspring of dams fed a high-fat diet</article-title>. <source/>Int J Dev Neurosci
<year>2013</year>; <volume>31</volume>: <fpage>731</fpage>–739.<pub-id pub-id-type="pmid">24071008</pub-id></mixed-citation>
</ref>
<ref id="bib189">
<mixed-citation publication-type="journal">Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR et al. <article-title>Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin</article-title>. <source/>Nature
<year>2000</year>; <volume>405</volume>: <fpage>458</fpage>–462.<pub-id pub-id-type="pmid">10839541</pub-id></mixed-citation>
</ref>
<ref id="bib190">
<mixed-citation publication-type="journal">Lyte M, Li W, Opitz N, Gaykema RP, Goehler LE. <article-title>Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia <italic>Citrobacter rodentium</italic></article-title>. <source/>Physiol Behav
<year>2006</year>; <volume>89</volume>: <fpage>350</fpage>–357.<pub-id pub-id-type="pmid">16887154</pub-id></mixed-citation>
</ref>
<ref id="bib191">
<mixed-citation publication-type="journal">Perez-Burgos A, Wang B, Mao YK, Mistry B, McVey Neufeld KA, Bienenstock J et al. <article-title>Psychoactive bacteria <italic>Lactobacillus rhamnosus</italic> (JB-1) elicits rapid frequency facilitation in vagal afferents</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol
<year>2013</year>; <volume>304</volume>: <fpage>G211</fpage>–G220.<pub-id pub-id-type="pmid">23139216</pub-id></mixed-citation>
</ref>
<ref id="bib192">
<mixed-citation publication-type="journal">Dantzer R. <article-title>Cytokine, sickness behavior, and depression</article-title>. <source/>Immunol Allergy Clin North Am
<year>2009</year>; <volume>29</volume>: <fpage>247</fpage>–264.<pub-id pub-id-type="pmid">19389580</pub-id></mixed-citation>
</ref>
<ref id="bib193">
<mixed-citation publication-type="journal">Macfarlane S, Macfarlane GT. <article-title>Regulation of short-chain fatty acid production</article-title>. <source/>Proc Nutr Soc
<year>2003</year>; <volume>62</volume>: <fpage>67</fpage>–72.<pub-id pub-id-type="pmid">12740060</pub-id></mixed-citation>
</ref>
<ref id="bib194">
<mixed-citation publication-type="journal">Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S et al. <article-title>Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)</article-title>. <source/>Proc Natl Acad Sci USA
<year>2011</year>; <volume>108</volume>: <fpage>8030</fpage>–8035.<pub-id pub-id-type="pmid">21518883</pub-id></mixed-citation>
</ref>
<ref id="bib195">
<mixed-citation publication-type="journal">Nøhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS et al. <article-title>GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes</article-title>. <source/>Endocrinology
<year>2013</year>; <volume>154</volume>: <fpage>3552</fpage>–3564.<pub-id pub-id-type="pmid">23885020</pub-id></mixed-citation>
</ref>
<ref id="bib196">
<mixed-citation publication-type="journal">MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boon F et al. <article-title>Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders</article-title>. <source/>Behav Brain Res
<year>2007</year>; <volume>176</volume>: <fpage>149</fpage>–169.<pub-id pub-id-type="pmid">16950524</pub-id></mixed-citation>
</ref>
<ref id="bib197">
<mixed-citation publication-type="journal">MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP. <article-title>Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder</article-title>. <source/>Behav Brain Res
<year>2011</year>; <volume>217</volume>: <fpage>47</fpage>–54.<pub-id pub-id-type="pmid">20937326</pub-id></mixed-citation>
</ref>
<ref id="bib198">
<mixed-citation publication-type="journal">Macfabe DF. <article-title>Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders</article-title>. <source/>Microb Ecol Health Dis
<year>2012</year>; <volume>23</volume>; doi: 10.3402/mehd.v23i0.19260.</mixed-citation>
</ref>
<ref id="bib199">
<mixed-citation publication-type="journal">de Theije CG, Wopereis H, Ramadan M, van Eijndthoven T, Lambert J, Knol J et al. <article-title>Altered gut microbiota and activity in a murine model of autism spectrum disorders</article-title>. <source/>Brain Behav Immun
<year>2014</year>; <volume>37</volume>: <fpage>197</fpage>–206.<pub-id pub-id-type="pmid">24333160</pub-id></mixed-citation>
</ref>
<ref id="bib200">
<mixed-citation publication-type="journal">Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E et al. <article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>. <source/>Nat Neurosci
<year>2015</year>; <volume>18</volume>: <fpage>965</fpage>–977.<pub-id pub-id-type="pmid">26030851</pub-id></mixed-citation>
</ref>
<ref id="bib201">
<mixed-citation publication-type="journal">Ransohoff RM, Perry VH. <article-title>Microglial physiology: unique stimuli, specialized responses</article-title>. <source/>Annu Rev Immunol
<year>2009</year>; <volume>27</volume>: <fpage>119</fpage>–145.<pub-id pub-id-type="pmid">19302036</pub-id></mixed-citation>
</ref>
<ref id="bib202">
<mixed-citation publication-type="journal">Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. <article-title>Physiology of microglia</article-title>. <source/>Physiol Rev
<year>2011</year>; <volume>91</volume>: <fpage>461</fpage>–553.<pub-id pub-id-type="pmid">21527731</pub-id></mixed-citation>
</ref>
<ref id="bib203">
<mixed-citation publication-type="journal">Prinz M, Priller J. <article-title>Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease</article-title>. <source/>Nat Rev Neurosci
<year>2014</year>; <volume>15</volume>: <fpage>300</fpage>–312.<pub-id pub-id-type="pmid">24713688</pub-id></mixed-citation>
</ref>
<ref id="bib204">
<mixed-citation publication-type="journal">Schéle E, Grahnemo L, Anesten F, Hallén A, Bäckhed F, Jansson JO. <article-title>The gut microbiota reduces leptin sensitivity and the expression of the obesity-suppressing neuropeptides proglucagon (Gcg) and brain-derived neurotrophic factor (Bdnf) in the central nervous system</article-title>. <source/>Endocrinology
<year>2013</year>; <volume>154</volume>: <fpage>3643</fpage>–3651.<pub-id pub-id-type="pmid">23892476</pub-id></mixed-citation>
</ref>
<ref id="bib205">
<mixed-citation publication-type="journal">Cameron J, Doucet E. <article-title>Getting to the bottom of feeding behaviour: who's on top</article-title>? <source/>Appl Physiol Nutr Metab
<year>2007</year>; <volume>32</volume>: <fpage>177</fpage>–189.<pub-id pub-id-type="pmid">17486158</pub-id></mixed-citation>
</ref>
<ref id="bib206">
<mixed-citation publication-type="journal">Wren AM, Bloom SR. <article-title>Gut hormones and appetite control</article-title>. <source/>Gastroenterology
<year>2007</year>; <volume>132</volume>: <fpage>2116</fpage>–2130.<pub-id pub-id-type="pmid">17498507</pub-id></mixed-citation>
</ref>
<ref id="bib207">
<mixed-citation publication-type="journal">Erspamer V. <article-title>Pharmacology of indole-alkylamines</article-title>. <source/>Pharmacol Rev
<year>1954</year>; <volume>6</volume>: <fpage>425</fpage>–487.<pub-id pub-id-type="pmid">13236482</pub-id></mixed-citation>
</ref>
<ref id="bib208">
<mixed-citation publication-type="journal">Keating DJ, Spencer NJ. <article-title>Release of 5-hydroxytryptamine from the mucosa is not required for the generation or propagation of colonic migrating motor complexes</article-title>. <source/>Gastroenterology
<year>2010</year>; <volume>138</volume>: <fpage>659</fpage>–670.e1–2.<pub-id pub-id-type="pmid">19782081</pub-id></mixed-citation>
</ref>
<ref id="bib209">
<mixed-citation publication-type="journal">Spencer NJ, Nicholas SJ, Robinson L, Kyloh M, Flack N, Brookes SJ et al. <article-title>Mechanisms underlying distension-evoked peristalsis in guinea pig distal colon: is there a role for enterochromaffin cells</article-title>? <source/>Am J Physiol Gastrointest Liver Physiol
<year>2011</year>; <volume>301</volume>: <fpage>G519</fpage>–G527.<pub-id pub-id-type="pmid">21700904</pub-id></mixed-citation>
</ref>
<ref id="bib210">
<mixed-citation publication-type="journal">Young RL, Lumsden AL, Keating DJ. <article-title>Gut serotonin is a regulator of obesity and metabolism</article-title>. <source/>Gastroenterology
<year>2015</year>; <volume>149</volume>: <fpage>253</fpage>–255.<pub-id pub-id-type="pmid">26025313</pub-id></mixed-citation>
</ref>
<ref id="bib211">
<mixed-citation publication-type="journal">Bertrand PP, Kunze WA, Bornstein JC, Furness JB, Smith ML. <article-title>Analysis of the responses of myenteric neurons in the small intestine to chemical stimulation of the mucosa</article-title>. <source/>Am J Physiol
<year>1997</year>; <volume>273</volume>: <fpage>G422</fpage>–G435.<pub-id pub-id-type="pmid">9277422</pub-id></mixed-citation>
</ref>
<ref id="bib212">
<mixed-citation publication-type="journal">Cook EH Jr, Leventhal BL, Heller W, Metz J, Wainwright M, Freedman DX. <article-title>Autistic children and their first-degree relatives: relationships between serotonin and norepinephrine levels and intelligence</article-title>. <source/>J Neuropsychiatry Clin Neurosci
<year>1990</year>; <volume>2</volume>: <fpage>268</fpage>–274.<pub-id pub-id-type="pmid">2136085</pub-id></mixed-citation>
</ref>
<ref id="bib213">
<mixed-citation publication-type="journal">Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D, Tabuteau F et al. <article-title>Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives</article-title>. <source/>Biol Psychiatry
<year>1999</year>; <volume>45</volume>: <fpage>158</fpage>–163.<pub-id pub-id-type="pmid">9951562</pub-id></mixed-citation>
</ref>
<ref id="bib214">
<mixed-citation publication-type="journal">Hranilovic D, Bujas-Petkovic Z, Vragovic R, Vuk T, Hock K, Jernej B. <article-title>Hyperserotonemia in adults with autistic disorder</article-title>. <source/>J Autism Dev Disord
<year>2007</year>; <volume>37</volume>: <fpage>1934</fpage>–1940.<pub-id pub-id-type="pmid">17165147</pub-id></mixed-citation>
</ref>
<ref id="bib215">
<mixed-citation publication-type="journal">Mulder EJ, Anderson GM, Kema IP, de Bildt A, van Lang ND, den Boer JA et al. <article-title>Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates</article-title>. <source/>J Am Acad Child Adolesc Psychiatry
<year>2004</year>; <volume>43</volume>: <fpage>491</fpage>–499.<pub-id pub-id-type="pmid">15187810</pub-id></mixed-citation>
</ref>
<ref id="bib216">
<mixed-citation publication-type="journal">McBride PA, Anderson GM, Hertzig ME, Sweeney JA, Kream J, Cohen DJ et al. <article-title>Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study</article-title>. <source/>Arch Gen Psychiatry
<year>1989</year>; <volume>46</volume>: <fpage>213</fpage>–221.<pub-id pub-id-type="pmid">2919950</pub-id></mixed-citation>
</ref>
<ref id="bib217">
<mixed-citation publication-type="journal">Tsavkelova EA, Botvinko IV, Kudrin VS, Oleskin AV. <article-title>Detection of neurotransmitter amines in microorganisms with the use of high-performance liquid chromatography</article-title>. <source/>Dokl Biochem
<year>2000</year>; <volume>372</volume>: <fpage>115</fpage>–117.<pub-id pub-id-type="pmid">10935181</pub-id></mixed-citation>
</ref>
<ref id="bib218">
<mixed-citation publication-type="journal">Barrett E, Ross RP, O'Toole PW, Fitzgerald GF, Stanton C. <article-title>γ-Aminobutyric acid production by culturable bacteria from the human intestine</article-title>. <source/>J Appl Microbiol
<year>2012</year>; <volume>113</volume>: <fpage>411</fpage>–417.<pub-id pub-id-type="pmid">22612585</pub-id></mixed-citation>
</ref>
<ref id="bib219">
<mixed-citation publication-type="journal">Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W et al. <article-title>Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling</article-title>. <source/>PLoS One
<year>2012</year>; <volume>7</volume>: <fpage>e31951</fpage>.<pub-id pub-id-type="pmid">22384111</pub-id></mixed-citation>
</ref>
<ref id="bib220">
<mixed-citation publication-type="journal">Stephenson M, Rowatt E. <article-title>The production of acetylcholine by a strain of <italic>Lactobacillus plantarum</italic></article-title>. <source/>J Gen Microbiol
<year>1947</year>; <volume>1</volume>: <fpage>279</fpage>–298.<pub-id pub-id-type="pmid">20270627</pub-id></mixed-citation>
</ref>
<ref id="bib221">
<mixed-citation publication-type="journal">Ridlon JM, Kang DJ, Hylemon PB, Bajaj JS. <article-title>Bile acids and the gut microbiome</article-title>. <source/>Curr Opin Gastroenterol
<year>2014</year>; <volume>30</volume>: <fpage>332</fpage>–338.<pub-id pub-id-type="pmid">24625896</pub-id></mixed-citation>
</ref>
<ref id="bib222">
<mixed-citation publication-type="journal">McMillin M, Frampton G, Quinn M, Divan A, Grant S, Patel N et al. <article-title>Suppression of the HPA axis during cholestasis can be attributed to hypothalamic bile acid signaling</article-title>. <source/>Mol Endocrinol
<year>2015</year>; <volume>29</volume>: <fpage>1720</fpage>–1730.<pub-id pub-id-type="pmid">26431088</pub-id></mixed-citation>
</ref>
<ref id="bib223">
<mixed-citation publication-type="journal">Le Floc'h N, Otten W, Merlot E. <article-title>Tryptophan metabolism, from nutrition to potential therapeutic applications</article-title>. <source/>Amino Acids
<year>2011</year>; <volume>41</volume>: <fpage>1195</fpage>–1205.<pub-id pub-id-type="pmid">20872026</pub-id></mixed-citation>
</ref>
<ref id="bib224">
<mixed-citation publication-type="journal">Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA. <article-title>Tryptophan metabolism in the central nervous system: medical implications</article-title>. <source/>Expert Rev Mol Med
<year>2006</year>; <volume>8</volume>: <fpage>1</fpage>–27.</mixed-citation>
</ref>
<ref id="bib225">
<mixed-citation publication-type="journal">Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. <article-title>Kynurenines in the mammalian brain: when physiology meets pathology</article-title>. <source/>Nat Rev Neurosci
<year>2012</year>; <volume>13</volume>: <fpage>465</fpage>–477.<pub-id pub-id-type="pmid">22678511</pub-id></mixed-citation>
</ref>
<ref id="bib226">
<mixed-citation publication-type="journal">Mawe GM, Hoffman JM. <article-title>Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets</article-title>. <source/>Nat Rev Gastroenterol Hepatol
<year>2013</year>; <volume>10</volume>: <fpage>473</fpage>–486.<pub-id pub-id-type="pmid">23797870</pub-id></mixed-citation>
</ref>
<ref id="bib227">
<mixed-citation publication-type="journal">Spiller R. <article-title>Serotonin and GI clinical disorders</article-title>. <source/>Neuropharmacology
<year>2008</year>; <volume>55</volume>: <fpage>1072</fpage>–1080.<pub-id pub-id-type="pmid">18687345</pub-id></mixed-citation>
</ref>
<ref id="bib228">
<mixed-citation publication-type="journal">Gershon MD. <article-title>5-Hydroxytryptamine (serotonin) in the gastrointestinal tract</article-title>. <source/>Curr Opin Endocrinol Diabetes Obes
<year>2013</year>; <volume>20</volume>: <fpage>14</fpage>–21.<pub-id pub-id-type="pmid">23222853</pub-id></mixed-citation>
</ref>
<ref id="bib229">
<mixed-citation publication-type="journal">Milligan TW, Doran TI, Straus DC, Mattingly SJ. <article-title>Growth and amino acid requirements of various strains of group B streptococci</article-title>. <source/>J Clin Microbiol
<year>1978</year>; <volume>7</volume>: <fpage>28</fpage>–33.<pub-id pub-id-type="pmid">342537</pub-id></mixed-citation>
</ref>
<ref id="bib230">
<mixed-citation publication-type="journal">Li G, Young KD. <article-title>Indole production by the tryptophanase TnaA in <italic>Escherichia coli</italic> is determined by the amount of exogenous tryptophan</article-title>. <source/>Microbiology
<year>2013</year>; <volume>159</volume>: <fpage>402</fpage>–410.<pub-id pub-id-type="pmid">23397453</pub-id></mixed-citation>
</ref>
<ref id="bib231">
<mixed-citation publication-type="journal">Lee Y, Yeom J, Kim J, Jung J, Jeon CO, Park W. <article-title>Phenotypic and physiological alterations by heterologous acylhomoserine lactone synthase expression in <italic>Pseudomonas putida</italic></article-title>. <source/>Microbiology
<year>2010</year>; <volume>156</volume>: <fpage>3762</fpage>–3772.<pub-id pub-id-type="pmid">20705668</pub-id></mixed-citation>
</ref>
<ref id="bib232">
<mixed-citation publication-type="journal">Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. <article-title>Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan</article-title>. <source/>Arch Gen Psychiatry
<year>1990</year>; <volume>47</volume>: <fpage>411</fpage>–418.<pub-id pub-id-type="pmid">2184795</pub-id></mixed-citation>
</ref>
<ref id="bib233">
<mixed-citation publication-type="journal">Hood SD, Bell CJ, Nutt DJ. <article-title>Acute tryptophan depletion. Part I: rationale and methodology</article-title>. <source/>Aust N Z J Psychiatry
<year>2005</year>; <volume>39</volume>: <fpage>558</fpage>–564.<pub-id pub-id-type="pmid">15996136</pub-id></mixed-citation>
</ref>
<ref id="bib234">
<mixed-citation publication-type="other">Wong M-L, Inserra A, Lewis MD, Mastronardi CA, Kentish S, Leong L et al. <article-title>Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition</article-title>. <source/>Mol Psychiatry
<year>2016</year> (in press).</mixed-citation>
</ref>
<ref id="bib235">
<mixed-citation publication-type="other">Zheng P, Zeng B, Zhou C, Liu M, Xu X, Zeng L et al. <article-title>Microbiome remodeling induces depression-like behaviors in a pathway that is mediated through the host's metabolism</article-title>. <source/>Mol Psychiatry
<year>2016</year>; doi: 10.1038/mp.2016.44 (in press).</mixed-citation>
</ref>
<ref id="bib236">
<mixed-citation publication-type="journal">Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R. <article-title>Development of the human gastrointestinal microbiota and insights from high-throughput sequencing</article-title>. <source/>Gastroenterology
<year>2011</year>; <volume>140</volume>: <fpage>1713</fpage>–1719.<pub-id pub-id-type="pmid">21530737</pub-id></mixed-citation>
</ref>
<ref id="bib237">
<mixed-citation publication-type="journal">Salthouse TA. <article-title>Decomposing age correlations on neuropsychological and cognitive variables</article-title>. <source/>J Int Neuropsychol Soc
<year>2009</year>; <volume>15</volume>: <fpage>650</fpage>–661.<pub-id pub-id-type="pmid">19570312</pub-id></mixed-citation>
</ref>
<ref id="bib238">
<mixed-citation publication-type="journal">Schaffer S, Asseburg H, Kuntz S, Muller WE, Eckert GP. <article-title>Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria</article-title>. <source/>Mol Neurobiol
<year>2012</year>; <volume>46</volume>: <fpage>161</fpage>–178.<pub-id pub-id-type="pmid">22706880</pub-id></mixed-citation>
</ref>
<ref id="bib239">
<mixed-citation publication-type="journal">Caracciolo B, Xu W, Collins S, Fratiglioni L. <article-title>Cognitive decline, dietary factors and gut-brain interactions</article-title>. <source/>Mech Ageing Dev
<year>2014</year>; <volume>136-137</volume>: <fpage>59</fpage>–69.<pub-id pub-id-type="pmid">24333791</pub-id></mixed-citation>
</ref>
<ref id="bib240">
<mixed-citation publication-type="journal">Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E et al. <article-title>Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians</article-title>. <source/>PLoS One
<year>2010</year>; <volume>5</volume>: <fpage>e10667</fpage>.<pub-id pub-id-type="pmid">20498852</pub-id></mixed-citation>
</ref>
<ref id="bib241">
<mixed-citation publication-type="journal">Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S et al. <article-title>Composition, variability, and temporal stability of the intestinal microbiota of the elderly</article-title>. <source/>Proc Natl Acad Sci USA
<year>2011</year>; <volume>108</volume>: <fpage>4586</fpage>–4591.<pub-id pub-id-type="pmid">20571116</pub-id></mixed-citation>
</ref>
<ref id="bib242">
<mixed-citation publication-type="journal">Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M, Ottaviani E et al. <article-title>Inflamm-aging. An evolutionary perspective on immunosenescence</article-title>. <source/>Ann N Y Acad Sci
<year>2000</year>; <volume>908</volume>: <fpage>244</fpage>–254.<pub-id pub-id-type="pmid">10911963</pub-id></mixed-citation>
</ref>
<ref id="bib243">
<mixed-citation publication-type="journal">Griffin WS. <article-title>Neuroinflammatory cytokine signaling and Alzheimer's disease</article-title>. <source/>N Engl J Med
<year>2013</year>; <volume>368</volume>: <fpage>770</fpage>–771.<pub-id pub-id-type="pmid">23425171</pub-id></mixed-citation>
</ref>
<ref id="bib244">
<mixed-citation publication-type="journal">Hassing LB, Dahl AK, Thorvaldsson V, Berg S, Gatz M, Pedersen NL et al. <article-title>Overweight in midlife and risk of dementia: a 40-year follow-up study</article-title>. <source/>Int J Obes (Lond)
<year>2009</year>; <volume>33</volume>: <fpage>893</fpage>–898.<pub-id pub-id-type="pmid">19506566</pub-id></mixed-citation>
</ref>
<ref id="bib245">
<mixed-citation publication-type="journal">Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B et al. <article-title>Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease</article-title>. <source/>Arch Neurol
<year>2005</year>; <volume>62</volume>: <fpage>1556</fpage>–1560.<pub-id pub-id-type="pmid">16216938</pub-id></mixed-citation>
</ref>
<ref id="bib246">
<mixed-citation publication-type="journal">Cheng CM, Chiu MJ, Wang JH, Liu HC, Shyu YI, Huang GH et al. <article-title>Cognitive stimulation during hospitalization improves global cognition of older Taiwanese undergoing elective total knee and hip replacement surgery</article-title>. <source/>J Adv Nurs
<year>2012</year>; <volume>68</volume>: <fpage>1322</fpage>–1329.<pub-id pub-id-type="pmid">21988083</pub-id></mixed-citation>
</ref>
<ref id="bib247">
<mixed-citation publication-type="journal">Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ. <article-title>An update on type 2 diabetes, vascular dementia and Alzheimer's disease</article-title>. <source/>Exp Gerontol
<year>2012</year>; <volume>47</volume>: <fpage>858</fpage>–864.<pub-id pub-id-type="pmid">22884853</pub-id></mixed-citation>
</ref>
<ref id="bib248">
<mixed-citation publication-type="journal">Lupien SJ, McEwen BS, Gunnar MR, Heim C. <article-title>Effects of stress throughout the lifespan on the brain, behaviour and cognition</article-title>. <source/>Nat Rev Neurosci
<year>2009</year>; <volume>10</volume>: <fpage>434</fpage>–445.<pub-id pub-id-type="pmid">19401723</pub-id></mixed-citation>
</ref>
<ref id="bib249">
<mixed-citation publication-type="journal">Berger M, Gray JA, Roth BL. <article-title>The expanded biology of serotonin</article-title>. <source/>Annu Rev Med
<year>2009</year>; <volume>60</volume>: <fpage>355</fpage>–366.<pub-id pub-id-type="pmid">19630576</pub-id></mixed-citation>
</ref>
<ref id="bib250">
<mixed-citation publication-type="journal">Fidalgo AR. <article-title>Experimental insights into age-exacerbated cognitive dysfunction after peripheral surgery</article-title>. <source/>Aging Cell
<year>2013</year>; <volume>12</volume>: <fpage>523</fpage>–524.<pub-id pub-id-type="pmid">23461580</pub-id></mixed-citation>
</ref>
<ref id="bib251">
<mixed-citation publication-type="journal">Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S et al. <article-title>Gut microbiota composition correlates with diet and health in the elderly</article-title>. <source/>Nature
<year>2012</year>; <volume>488</volume>: <fpage>178</fpage>–184.<pub-id pub-id-type="pmid">22797518</pub-id></mixed-citation>
</ref>
<ref id="bib252">
<mixed-citation publication-type="journal">Titova OE, Ax E, Brooks SJ, Sjögren P, Cederholm T, Kilander L et al. <article-title>Mediterranean diet habits in older individuals: associations with cognitive functioning and brain volumes</article-title>. <source/>Exp Gerontol
<year>2013</year>; <volume>48</volume>: <fpage>1443</fpage>–1448.<pub-id pub-id-type="pmid">24126083</pub-id></mixed-citation>
</ref>
<ref id="bib253">
<mixed-citation publication-type="journal">Kesby JP, Kim JJ, Scadeng M, Woods G, Kado DM, Olefsky JM et al. <article-title>Spatial cognition in adult and aged mice exposed to high-fat diet</article-title>. <source/>PLoS One
<year>2015</year>; <volume>10</volume>: <fpage>e0140034</fpage>.<pub-id pub-id-type="pmid">26448649</pub-id></mixed-citation>
</ref>
<ref id="bib254">
<mixed-citation publication-type="journal">Jin K, Simpkins JW, Ji X, Leis M, Stambler I. <article-title>The critical need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population</article-title>. <source/>Aging Dis
<year>2014</year>; <volume>6</volume>: <fpage>1</fpage>–5.<pub-id pub-id-type="pmid">25657847</pub-id></mixed-citation>
</ref>
<ref id="bib255">
<mixed-citation publication-type="journal">Suzman R, Beard JR, Boerma T, Chatterji S. <article-title>Health in an ageing world—what do we know</article-title>? <source/>Lancet
<year>2015</year>; <volume>385</volume>: <fpage>484</fpage>–486.<pub-id pub-id-type="pmid">25468156</pub-id></mixed-citation>
</ref>
<ref id="bib256">
<mixed-citation publication-type="journal">Chatterji S, Byles J, Cutler D, Seeman T, Verdes E. <article-title>Health, functioning, and disability in older adults—present status and future implications</article-title>. <source/>Lancet
<year>2015</year>; <volume>385</volume>: <fpage>563</fpage>–575.<pub-id pub-id-type="pmid">25468158</pub-id></mixed-citation>
</ref>
<ref id="bib257">
<mixed-citation publication-type="journal">Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. <article-title>Effects of the probiotic <italic>Bifidobacterium infantis</italic> in the maternal separation model of depression</article-title>. <source/>Neuroscience
<year>2010</year>; <volume>170</volume>: <fpage>1179</fpage>–1188.<pub-id pub-id-type="pmid">20696216</pub-id></mixed-citation>
</ref>
<ref id="bib258">
<mixed-citation publication-type="journal">Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X et al. <article-title>Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice</article-title>. <source/>Gastroenterology
<year>2010</year>; <volume>139</volume>: <fpage>2102</fpage>–2112.e1.<pub-id pub-id-type="pmid">20600016</pub-id></mixed-citation>
</ref>
<ref id="bib259">
<mixed-citation publication-type="journal">Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X et al. <article-title>The anxiolytic effect of <italic>Bifidobacterium longum</italic> NCC3001 involves vagal pathways for gut-brain communication</article-title>. <source/>Neurogastroenterol Motil
<year>2011</year>; <volume>23</volume>: <fpage>1132</fpage>–1139.<pub-id pub-id-type="pmid">21988661</pub-id></mixed-citation>
</ref>
<ref id="bib260">
<mixed-citation publication-type="journal">Zareie M, Johnson-Henry K, Jury J, Yang PC, Ngan BY, McKay DM et al. <article-title>Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress</article-title>. <source/>Gut
<year>2006</year>; <volume>55</volume>: <fpage>1553</fpage>–1560.<pub-id pub-id-type="pmid">16638791</pub-id></mixed-citation>
</ref>
<ref id="bib261">
<mixed-citation publication-type="journal">Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L et al. <article-title>Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats</article-title>. <source/>Psychoneuroendocrinology
<year>2012</year>; <volume>37</volume>: <fpage>1885</fpage>–1895.<pub-id pub-id-type="pmid">22541937</pub-id></mixed-citation>
</ref>
<ref id="bib262">
<mixed-citation publication-type="journal">Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B et al. <article-title>Consumption of fermented milk product with probiotic modulates brain activity</article-title>. <source/>Gastroenterology
<year>2013</year>; <volume>144</volume>: <fpage>1394</fpage>–401.e1–4.<pub-id pub-id-type="pmid">23474283</pub-id></mixed-citation>
</ref>
<ref id="bib263">
<mixed-citation publication-type="journal">Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. <article-title>The probiotic <italic>Bifidobacteria infantis</italic>: an assessment of potential antidepressant properties in the rat</article-title>. <source/>J Psychiatr Res
<year>2008</year>; <volume>43</volume>: <fpage>164</fpage>–174.<pub-id pub-id-type="pmid">18456279</pub-id></mixed-citation>
</ref>
<ref id="bib264">
<mixed-citation publication-type="journal">Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC et al. <article-title>Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites</article-title>. <source/>Proc Natl Acad Sci USA
<year>2009</year>; <volume>106</volume>: <fpage>3698</fpage>–3703.<pub-id pub-id-type="pmid">19234110</pub-id></mixed-citation>
</ref>
<ref id="bib265">
<mixed-citation publication-type="journal">Hanstock TL, Mallet PE, Clayton EH. <article-title>Increased plasma d-lactic acid associated with impaired memory in rats</article-title>. <source/>Physiol Behav
<year>2010</year>; <volume>101</volume>: <fpage>653</fpage>–659.<pub-id pub-id-type="pmid">20888356</pub-id></mixed-citation>
</ref>
<ref id="bib266">
<mixed-citation publication-type="journal">Savignac HM, Corona G, Mills H, Chen L, Spencer JP, Tzortzis G et al. <article-title>Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine</article-title>. <source/>Neurochem Int
<year>2013</year>; <volume>63</volume>: <fpage>756</fpage>–764.<pub-id pub-id-type="pmid">24140431</pub-id></mixed-citation>
</ref>
<ref id="bib267">
<mixed-citation publication-type="journal">Savignac HM, Couch Y, Stratford M, Bannerman DM, Tzortzis G, Anthony DC et al. <article-title>Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice</article-title>. <source/>Brain Behav Immun
<year>2015</year>; <volume>52</volume>: <fpage>120</fpage>–131.</mixed-citation>
</ref>
<ref id="bib268">
<mixed-citation publication-type="journal">Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, Burnet PW. <article-title>Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers</article-title>. <source/>Psychopharmacology (Berl)
<year>2015</year>; <volume>232</volume>: <fpage>1793</fpage>–1801.<pub-id pub-id-type="pmid">25449699</pub-id></mixed-citation>
</ref>
<ref id="bib269">
<mixed-citation publication-type="journal">Pusceddu MM, El Aidy S, Crispie F, O'Sullivan O, Cotter P, Stanton C et al. <article-title>N-3 polyunsaturated fatty acids (PUFAs) reverse the impact of early-life stress on the gut microbiota</article-title>. <source/>PLoS One
<year>2015</year>; <volume>10</volume>: <fpage>e0139721</fpage>.<pub-id pub-id-type="pmid">26426902</pub-id></mixed-citation>
</ref>
<ref id="bib270">
<mixed-citation publication-type="other">Mental Health Foundation, 2007. Available at: http://www.mentalhealth.org.uk/help-information/mental-health-a-z/D/diet/ (accessed on January 2016).</mixed-citation>
</ref>
<ref id="bib271">
<mixed-citation publication-type="journal">Rogers GB, Bruce KD. <article-title>Challenges and opportunities for faecal microbiota transplantation therapy</article-title>. <source/>Epidemiol Infect
<year>2013</year>; <volume>141</volume>: <fpage>2235</fpage>–2242.<pub-id pub-id-type="pmid">23735045</pub-id></mixed-citation>
</ref>
<ref id="bib272">
<mixed-citation publication-type="journal">Collins SM, Kassam Z, Bercik P. <article-title>The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications</article-title>. <source/>Curr Opin Microbiol
<year>2013</year>; <volume>16</volume>: <fpage>240</fpage>–245.<pub-id pub-id-type="pmid">23845749</pub-id></mixed-citation>
</ref>
<ref id="bib273">
<mixed-citation publication-type="journal">Smith PA. <article-title>The tantalizing links between gut microbes and the brain</article-title>. <source/>Nature
<year>2015</year>; <volume>526</volume>: <fpage>312</fpage>–314.<pub-id pub-id-type="pmid">26469024</pub-id></mixed-citation>
</ref>
<ref id="bib274">
<mixed-citation publication-type="journal">Daskalakis NP, Bagot RC, Parker KJ, Vinkers CH, de Kloet ER. <article-title>The three-hit concept of vulnerability and resilience: toward understanding adaptation to early-life adversity outcome</article-title>. <source/>Psychoneuroendocrinology
<year>2013</year>; <volume>38</volume>: <fpage>1858</fpage>–1873.<pub-id pub-id-type="pmid">23838101</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="fig1">
<label>Figure 1</label>
<caption>
<p>Communication pathways linking the gut microbiome with brain function.</p>
</caption>
<graphic xlink:href="mp201650f1" xmlns:xlink="http://www.w3.org/1999/xlink"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>